Loews Corp 10-Q for FY2026 Q1
Loews Corp (L)
10-Q
2026-05-04
For: 2026-03-31
View Original
Added on
May 04, 2026
About this 10-Q
Loews Corp filed this 10-Q on May 4, 2026, covering the quarter ended March 31, 2026 (FY2026 Q1).
Headline figures
Quarter ended March 31, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $4.56B
- up 1.4% from $4.49B a year earlier
- Net income
- $337M
- down 8.9% from net income of $370M a year earlier
- Diluted EPS
- $1.63
- down 6.3% from $1.74 a year earlier
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2026
OR
OF THE SECURITIES EXCHANGE ACT OF 1934
For the Transition Period From ____________ to _____________
Commission File Number 1-06541
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | ||||
(Address of principal executive offices) (Zip Code)
(212 ) 521-2000
(Registrant’s telephone number, including area code)
NOT APPLICABLE
(Former name, former address and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
| ☒ | No ☐ | |||||||||||||
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
| ☒ | No ☐ | |||||||||||||
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| ☒ | Accelerated filer | ☐ | Non-accelerated filer | ☐ | Smaller reporting company | ||||||||||||||||||
| Emerging growth company | | |||||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
| Yes | ☐ | No | ||||||||||||
As of May 1, 2026, there were 205,768,873 shares of the registrant’s common stock outstanding.
1 | ||||||||
INDEX
| Page | |||||
| No. | |||||
March 31, 2026 and December 31, 2025 | |||||
Three months ended March 31, 2026 and 2025 | |||||
Three months ended March 31, 2026 and 2025 | |||||
Three months ended March 31, 2026 and 2025 | |||||
Three months ended March 31, 2026 and 2025 | |||||
2 | ||||||||
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements.
Loews Corporation and Subsidiaries
CONSOLIDATED CONDENSED BALANCE SHEETS
(Unaudited)
| March 31, | December 31, | ||||||||||
| 2026 | 2025 | ||||||||||
| (Dollar amounts in millions, except per share data) | |||||||||||
| Assets: | |||||||||||
| Investments: | |||||||||||
Fixed maturities, amortized cost of $ | $ | $ | |||||||||
Equity securities, cost of $ | |||||||||||
| Limited partnership investments | |||||||||||
Other invested assets, primarily mortgage loans, less allowance for credit loss of $ | |||||||||||
| Short-term investments | |||||||||||
| Total investments | |||||||||||
| Cash | |||||||||||
| Receivables | |||||||||||
| Property, plant and equipment | |||||||||||
| Goodwill | |||||||||||
| Deferred non-insurance warranty acquisition expenses | |||||||||||
| Deferred acquisition costs of insurance subsidiaries | |||||||||||
| Other assets | |||||||||||
| Total assets | $ | $ | |||||||||
| Liabilities and Equity: | |||||||||||
| Insurance reserves: | |||||||||||
| Claim and claim adjustment expense | $ | $ | |||||||||
| Future policy benefits | |||||||||||
| Unearned premiums | |||||||||||
| Total insurance reserves | |||||||||||
| Payable to brokers | |||||||||||
| Short-term debt | |||||||||||
| Long-term debt | |||||||||||
| Deferred income taxes | |||||||||||
| Deferred non-insurance warranty revenue | |||||||||||
| Other liabilities | |||||||||||
| Total liabilities | |||||||||||
| Commitments and contingent liabilities | |||||||||||
Preferred stock, $ | |||||||||||
Authorized – | |||||||||||
Common stock, $ | |||||||||||
Authorized – | |||||||||||
Issued – | |||||||||||
| Additional paid-in capital | |||||||||||
| Retained earnings | |||||||||||
| Accumulated other comprehensive loss | ( | ( | |||||||||
Less treasury stock, at cost ( | ( | ||||||||||
| Total shareholders’ equity | |||||||||||
| Noncontrolling interests | |||||||||||
| Total equity | |||||||||||
| Total liabilities and equity | $ | $ | |||||||||
See accompanying Notes to Consolidated Condensed Financial Statements.
3 | ||||||||
Loews Corporation and Subsidiaries
CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS
(Unaudited)
Three Months Ended March 31 | 2026 | 2025 | ||||||||||||||||||||||||
| (In millions, except per share data) | ||||||||||||||||||||||||||
| Revenues: | ||||||||||||||||||||||||||
| Insurance premiums | $ | $ | ||||||||||||||||||||||||
| Net investment income | ||||||||||||||||||||||||||
| Investment losses | ( | ( | ||||||||||||||||||||||||
| Non-insurance warranty revenue | ||||||||||||||||||||||||||
| Operating revenues and other | ||||||||||||||||||||||||||
| Total | ||||||||||||||||||||||||||
| Expenses: | ||||||||||||||||||||||||||
Insurance claims and policyholders’ benefits (re-measurement loss of $ | ||||||||||||||||||||||||||
| Amortization of deferred acquisition costs | ||||||||||||||||||||||||||
| Non-insurance warranty expense | ||||||||||||||||||||||||||
| Operating expenses and other | ||||||||||||||||||||||||||
| Equity method (income) loss | ( | |||||||||||||||||||||||||
| Interest | ||||||||||||||||||||||||||
| Total | ||||||||||||||||||||||||||
| Income before income tax | ||||||||||||||||||||||||||
| Income tax expense | ( | ( | ||||||||||||||||||||||||
| Net income | ||||||||||||||||||||||||||
| Amounts attributable to noncontrolling interests | ( | ( | ||||||||||||||||||||||||
| Net income attributable to Loews Corporation | $ | $ | ||||||||||||||||||||||||
| Basic and diluted net income per share | $ | $ | ||||||||||||||||||||||||
| Weighted average shares outstanding: | ||||||||||||||||||||||||||
| Shares of common stock | ||||||||||||||||||||||||||
| Dilutive potential shares of common stock | ||||||||||||||||||||||||||
| Total weighted average shares outstanding assuming dilution | ||||||||||||||||||||||||||
See accompanying Notes to Consolidated Condensed Financial Statements.
4 | ||||||||
Loews Corporation and Subsidiaries
CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(Unaudited)
Three Months Ended March 31 | 2026 | 2025 | ||||||||||||||||||||||||
| (In millions) | ||||||||||||||||||||||||||
| Net income | $ | $ | ||||||||||||||||||||||||
| Other comprehensive income (loss), after tax | ||||||||||||||||||||||||||
| Changes in: | ||||||||||||||||||||||||||
| Net unrealized losses on investments with an allowance for credit losses | ( | ( | ||||||||||||||||||||||||
| Net unrealized gains (losses) on other investments | ( | |||||||||||||||||||||||||
| Total unrealized gains (losses) on investments | ( | |||||||||||||||||||||||||
| Impact of changes in discount rates used to measure long-duration contract liabilities | ( | |||||||||||||||||||||||||
| Unrealized gains (losses) on cash flow hedges | ( | |||||||||||||||||||||||||
| Pension and postretirement benefits | ||||||||||||||||||||||||||
| Foreign currency translation | ( | |||||||||||||||||||||||||
| Other comprehensive income (loss) | ( | |||||||||||||||||||||||||
| Comprehensive income | ||||||||||||||||||||||||||
| Amounts attributable to noncontrolling interests | ( | |||||||||||||||||||||||||
| Total comprehensive income attributable to Loews Corporation | $ | $ | ||||||||||||||||||||||||
See accompanying Notes to Consolidated Condensed Financial Statements.
5 | ||||||||
Loews Corporation and Subsidiaries
CONSOLIDATED CONDENSED STATEMENTS OF EQUITY
(Unaudited)
| Loews Corporation Shareholders | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Total | Common Stock | Additional Paid-in Capital | Retained Earnings | Accumulated Other Comprehensive Income (Loss) | Common Stock Held in Treasury | Noncontrolling Interests | ||||||||||||||||||||||||||||||||||||||||||||
| (In millions) | ||||||||||||||||||||||||||||||||||||||||||||||||||
Balance, December 31, 2024, as reported | $ | $ | $ | $ | $ | ( | $ | ( | $ | |||||||||||||||||||||||||||||||||||||||||
Cumulative effect adjustments from changes in accounting standards | ||||||||||||||||||||||||||||||||||||||||||||||||||
Balance, January 1, 2025, as adjusted | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||
| Net income | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive income | ||||||||||||||||||||||||||||||||||||||||||||||||||
Dividends paid ($ | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||||
| Purchase of subsidiary stock from noncontrolling interests | ( | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||
| Purchases of Loews Corporation treasury stock | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||
| Stock-based compensation | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||
| Other | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||
Balance, March 31, 2025 | $ | $ | $ | $ | $ | ( | $ | ( | $ | |||||||||||||||||||||||||||||||||||||||||
Balance, January 1, 2026 | $ | $ | $ | $ | $ | ( | $ | $ | ||||||||||||||||||||||||||||||||||||||||||
| Net income | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive loss | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||||
Dividends paid ($ | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||||
| Purchase of subsidiary stock from noncontrolling interests | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||||
| Purchases of Loews Corporation treasury stock | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||
| Stock-based compensation | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||
Balance, March 31, 2026 | $ | $ | $ | $ | $ | ( | $ | ( | $ | |||||||||||||||||||||||||||||||||||||||||
See accompanying Notes to Consolidated Condensed Financial Statements.
6 | ||||||||
Loews Corporation and Subsidiaries
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS
(Unaudited)
Three Months Ended March 31 | 2026 | 2025 | |||||||||
| (In millions) | |||||||||||
| Operating Activities: | |||||||||||
| Net income | $ | $ | |||||||||
| Adjustments to reconcile net income to net cash provided by operating activities, net | |||||||||||
| Changes in operating assets and liabilities, net: | |||||||||||
| Receivables | ( | ||||||||||
| Deferred acquisition costs | ( | ( | |||||||||
| Insurance reserves | |||||||||||
| Other assets | ( | ||||||||||
| Other liabilities | ( | ||||||||||
| Trading securities | ( | ( | |||||||||
| Net cash flow provided by operating activities | |||||||||||
| Investing Activities: | |||||||||||
| Purchases of fixed maturities | ( | ( | |||||||||
| Proceeds from sales of fixed maturities | |||||||||||
| Proceeds from maturities of fixed maturities | |||||||||||
| Purchases of equity securities | ( | ( | |||||||||
| Proceeds from sales of equity securities | |||||||||||
| Purchases of limited partnership investments | ( | ( | |||||||||
| Proceeds from sales of limited partnership investments | |||||||||||
| Purchases of property, plant and equipment | ( | ( | |||||||||
| Change in short-term investments | |||||||||||
| Other, net | ( | ||||||||||
| Net cash flow provided (used) by investing activities | ( | ||||||||||
| Financing Activities: | |||||||||||
| Dividends paid | ( | ( | |||||||||
| Dividends paid to noncontrolling interests | ( | ( | |||||||||
| Purchases of Loews Corporation treasury stock | ( | ( | |||||||||
| Purchases of subsidiary stock from noncontrolling interests | ( | ( | |||||||||
| Principal payments on debt | ( | ( | |||||||||
| Issuance of debt | |||||||||||
| Other, net | ( | ( | |||||||||
| Net cash flow used by financing activities | ( | ( | |||||||||
| Effect of foreign exchange rate on cash | ( | ||||||||||
| Net change in cash | |||||||||||
| Cash, beginning of period | |||||||||||
| Cash, end of period | $ | $ | |||||||||
See accompanying Notes to Consolidated Condensed Financial Statements.
7 | ||||||||
Loews Corporation and Subsidiaries
NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
(Unaudited)
1. Basis of Presentation
Loews Corporation is a holding company. Its consolidated operating subsidiaries are engaged in the following lines of business: commercial property and casualty insurance (CNA Financial Corporation (“CNA”), an approximately 92 % owned subsidiary); transportation and storage of natural gas and natural gas liquids, olefins and other hydrocarbons (Boardwalk Pipeline Partners, LP (“Boardwalk Pipelines”), a wholly owned subsidiary) and the operation of a chain of hotels (Loews Hotels Holding Corporation (“Loews Hotels & Co”), a wholly owned subsidiary). Unless the context otherwise requires, as used herein, the term “Company” means Loews Corporation including its subsidiaries, the term “Parent Company” means Loews Corporation excluding its subsidiaries and the term “Net income (loss) attributable to Loews Corporation” means Net income (loss) attributable to Loews Corporation shareholders. In addition, we own approximately 53 % of Altium Packaging LLC (“Altium Packaging”), an unconsolidated subsidiary accounted for under the equity method of accounting, which is engaged in the manufacture of rigid plastic packaging solutions.
In the opinion of management, the accompanying unaudited Consolidated Condensed Financial Statements reflect all adjustments (consisting of normal recurring accruals) necessary to present fairly the Company’s financial position as of March 31, 2026 and December 31, 2025, and its results of operations, comprehensive income (loss), changes in shareholders’ equity and cash flows for the three months ended March 31, 2026 and 2025, in each case in accordance with accounting principles generally accepted in the United States of America (“GAAP”). Results for the interim periods are not necessarily indicative of results for the entire year. These Consolidated Condensed Financial Statements should be read in conjunction with the Consolidated Financial Statements in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025.
Accounting Standards Pending Adoption - In November of 2024, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2024-03, “Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses.” The updated accounting guidance requires disaggregated disclosure of specified expense categories. The guidance also requires disclosure of total selling expenses and how the Company defines selling expenses. The guidance is effective for fiscal years beginning after December 15, 2026, and interim periods within annual periods beginning after December 15, 2027. Prospective application is required, with retrospective application permitted. The Company is currently evaluating the effect the updated guidance will have on its financial statement disclosures.
In September of 2025, the FASB issued ASU 2025-06, “Intangibles – Goodwill and Other – Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software.” The updated guidance changes the accounting for internal-use software by eliminating references to sequential project stages. Eligible software development cost capitalization will begin when: (1) management has authorized and committed to funding the software project and (2) it is probable that the software will be completed and used as intended. The guidance is effective for annual periods beginning after December 15, 2027, and interim periods within those annual periods, with early adoption permitted. The guidance may be applied using a prospective transition method, a retrospective transition method or a modified prospective transition method. The Company does not currently expect the updated guidance to have a material impact on its financial statements.
8 | ||||||||
2. Investments
Net investment income is as follows:
Three Months Ended March 31 | 2026 | 2025 | ||||||||||||||||||||||||
| (In millions) | ||||||||||||||||||||||||||
| Fixed maturity securities | $ | $ | ||||||||||||||||||||||||
| Limited partnership investments | ||||||||||||||||||||||||||
| Short-term investments | ||||||||||||||||||||||||||
| Equity securities (a) | ( | |||||||||||||||||||||||||
| Income (loss) from trading portfolio (a) | ( | |||||||||||||||||||||||||
| Other | ||||||||||||||||||||||||||
| Total investment income | ||||||||||||||||||||||||||
| Investment expenses | ( | ( | ||||||||||||||||||||||||
| Net investment income | $ | $ | ||||||||||||||||||||||||
(a) Aggregate income (loss) recognized due to the change in fair value of equity and trading portfolio securities held as of March 31, 2026 and 2025 | $ | ( | $ | ( | ||||||||||||||||||||||
Investment gains (losses) are as follows:
Three Months Ended March 31 | 2026 | 2025 | ||||||||||||||||||||||||
| (In millions) | ||||||||||||||||||||||||||
| Fixed maturity securities: | ||||||||||||||||||||||||||
| Gross gains | $ | $ | ||||||||||||||||||||||||
| Gross losses | ( | ( | ||||||||||||||||||||||||
| Investment losses on fixed maturity securities | ( | ( | ||||||||||||||||||||||||
| Equity securities (a) | ( | |||||||||||||||||||||||||
| Investment losses | $ | ( | $ | ( | ||||||||||||||||||||||
(a) Investment gains (losses) recognized due to the change in fair value of non-redeemable preferred stock included within equity securities held as of March 31, 2026 and 2025 | $ | ( | $ | ( | ||||||||||||||||||||||
9 | ||||||||
The available-for-sale impairment losses (gains) recognized in earnings by asset type are presented in the following table. The table includes losses (gains) on securities with an intention to sell and changes in the allowance for credit losses on securities since acquisition date:
Three Months Ended March 31 | 2026 | 2025 | ||||||||||||||||||||||||
| (In millions) | ||||||||||||||||||||||||||
| Fixed maturity securities available-for-sale: | ||||||||||||||||||||||||||
| Corporate and other bonds | $ | $ | ||||||||||||||||||||||||
| Asset-backed | ||||||||||||||||||||||||||
| Impairment losses recognized in earnings | $ | $ | ||||||||||||||||||||||||
There were no
10 | ||||||||
The following tables present a summary of fixed maturity securities:
| March 31, 2026 | Cost or Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Allowance for Credit Losses | Estimated Fair Value | ||||||||||||||||||||||||
| (In millions) | |||||||||||||||||||||||||||||
| Fixed maturity securities: | |||||||||||||||||||||||||||||
| Corporate and other bonds | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
| States, municipalities and political subdivisions | |||||||||||||||||||||||||||||
| Asset-backed: | |||||||||||||||||||||||||||||
| Residential mortgage-backed | |||||||||||||||||||||||||||||
| Commercial mortgage-backed | |||||||||||||||||||||||||||||
| Other asset-backed | |||||||||||||||||||||||||||||
| Total asset-backed | |||||||||||||||||||||||||||||
| U.S. Treasury and obligations of government sponsored enterprises | |||||||||||||||||||||||||||||
| Foreign government | |||||||||||||||||||||||||||||
| Redeemable preferred stock | |||||||||||||||||||||||||||||
| Fixed maturities available-for-sale | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
| Fixed maturities trading | |||||||||||||||||||||||||||||
| Total fixed maturity securities | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
| December 31, 2025 | |||||||||||||||||||||||||||||
| Fixed maturity securities: | |||||||||||||||||||||||||||||
| Corporate and other bonds | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
| States, municipalities and political subdivisions | |||||||||||||||||||||||||||||
| Asset-backed: | |||||||||||||||||||||||||||||
| Residential mortgage-backed | |||||||||||||||||||||||||||||
| Commercial mortgage-backed | |||||||||||||||||||||||||||||
| Other asset-backed | |||||||||||||||||||||||||||||
| Total asset-backed | |||||||||||||||||||||||||||||
| U.S. Treasury and obligations of government sponsored enterprises | |||||||||||||||||||||||||||||
| Foreign government | |||||||||||||||||||||||||||||
| Redeemable preferred stock | |||||||||||||||||||||||||||||
| Fixed maturities available-for-sale | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
| Fixed maturities trading | |||||||||||||||||||||||||||||
| Total fixed maturity securities | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
11 | ||||||||
The available-for-sale fixed maturity securities in a gross unrealized loss position for which an allowance for credit losses has not been recorded are as follows:
| Less than 12 Months | 12 Months or Longer | Total | |||||||||||||||||||||||||||||||||
| March 31, 2026 | Estimated Fair Value | Gross Unrealized Losses | Estimated Fair Value | Gross Unrealized Losses | Estimated Fair Value | Gross Unrealized Losses | |||||||||||||||||||||||||||||
| (In millions) | |||||||||||||||||||||||||||||||||||
| Fixed maturity securities: | |||||||||||||||||||||||||||||||||||
| Corporate and other bonds | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
| States, municipalities and political subdivisions | |||||||||||||||||||||||||||||||||||
| Asset-backed: | |||||||||||||||||||||||||||||||||||
| Residential mortgage-backed | |||||||||||||||||||||||||||||||||||
| Commercial mortgage-backed | |||||||||||||||||||||||||||||||||||
| Other asset-backed | |||||||||||||||||||||||||||||||||||
| Total asset-backed | |||||||||||||||||||||||||||||||||||
| U.S. Treasury and obligations of government-sponsored enterprises | |||||||||||||||||||||||||||||||||||
| Foreign government | |||||||||||||||||||||||||||||||||||
| Total fixed maturity securities | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
| December 31, 2025 | |||||||||||||||||||||||||||||||||||
| Fixed maturity securities: | |||||||||||||||||||||||||||||||||||
| Corporate and other bonds | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
| States, municipalities and political subdivisions | |||||||||||||||||||||||||||||||||||
| Asset-backed: | |||||||||||||||||||||||||||||||||||
| Residential mortgage-backed | |||||||||||||||||||||||||||||||||||
| Commercial mortgage-backed | |||||||||||||||||||||||||||||||||||
| Other asset-backed | |||||||||||||||||||||||||||||||||||
| Total asset-backed | |||||||||||||||||||||||||||||||||||
| U.S. Treasury and obligations of government-sponsored enterprises | |||||||||||||||||||||||||||||||||||
| Foreign government | |||||||||||||||||||||||||||||||||||
| Total fixed maturity securities | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
12 | ||||||||
The following table presents the estimated fair value and gross unrealized losses of available-for-sale fixed maturity securities in a gross unrealized loss position for which an allowance for credit loss has not been recorded, by ratings distribution.
| March 31, 2026 | December 31, 2025 | ||||||||||||||||||||||
| Estimated Fair Value | Gross Unrealized Losses | Estimated Fair Value | Gross Unrealized Losses | ||||||||||||||||||||
| (In millions) | |||||||||||||||||||||||
| U.S. Government, Government agencies and Government-sponsored enterprises | $ | $ | $ | $ | |||||||||||||||||||
| AAA | |||||||||||||||||||||||
| AA | |||||||||||||||||||||||
| A | |||||||||||||||||||||||
| BBB | |||||||||||||||||||||||
| Non-investment grade | |||||||||||||||||||||||
| Total | $ | $ | $ | $ | |||||||||||||||||||
Based on current facts and circumstances, the unrealized losses presented in the March 31, 2026 securities in the gross unrealized loss position table above are not indicative of the ultimate collectability of the current amortized cost of the securities, but rather are primarily attributable to changes in risk-free interest rates. In reaching this determination, the volatility in risk-free rates and credit spreads, as well as the fact that the unrealized losses are concentrated in investment grade issuers, were considered. Additionally, there is no current intent to sell securities with unrealized losses, nor is it more likely than not that sale will be required prior to recovery of amortized cost; accordingly, it was determined that there are no additional impairment losses to be recorded as of March 31, 2026.
The following tables present the activity related to the allowance on available-for-sale securities with credit impairments and purchased credit-deteriorated (“PCD”) assets. Accrued interest receivable on available-for-sale fixed maturity securities totaled $477 million, $470 million and $456 million as of March 31, 2026, December 31, 2025 and March 31, 2025 and are excluded from the estimate of expected credit losses and the amortized cost basis in the tables within this Note.
| Three months ended March 31, 2026 | Corporate and Other Bonds | Asset-backed | Total | ||||||||||||||
| (In millions) | |||||||||||||||||
| Allowance for credit losses: | |||||||||||||||||
Balance as of January 1, 2026 | $ | $ | $ | ||||||||||||||
| Additions to the allowance for credit losses: | |||||||||||||||||
| Securities for which credit losses were not previously recorded | |||||||||||||||||
Additional increases to the allowance for credit losses on securities that had an allowance recorded in a previous period | |||||||||||||||||
| Total allowance for credit losses | $ | $ | $ | ||||||||||||||
13 | ||||||||
| Three months ended March 31, 2025 | Corporate and Other Bonds | Asset-backed | Total | ||||||||||||||
| (In millions) | |||||||||||||||||
| Allowance for credit losses: | |||||||||||||||||
Balance as of January 1, 2025 | $ | $ | $ | ||||||||||||||
| Additions to the allowance for credit losses: | |||||||||||||||||
| Securities for which credit losses were not previously recorded | |||||||||||||||||
Additional increases to the allowance for credit losses on securities that had an allowance recorded in a previous period | |||||||||||||||||
| Total allowance for credit losses | $ | $ | $ | ||||||||||||||
Contractual Maturity
The following table presents available-for-sale fixed maturity securities by contractual maturity.
| March 31, 2026 | December 31, 2025 | ||||||||||||||||||||||
| Cost or Amortized Cost | Estimated Fair Value | Cost or Amortized Cost | Estimated Fair Value | ||||||||||||||||||||
| (In millions) | |||||||||||||||||||||||
| Due in one year or less | $ | $ | $ | $ | |||||||||||||||||||
| Due after one year through five years | |||||||||||||||||||||||
| Due after five years through ten years | |||||||||||||||||||||||
| Due after ten years | |||||||||||||||||||||||
| Total | $ | $ | $ | $ | |||||||||||||||||||
Actual maturities may differ from contractual maturities because certain securities may be called or prepaid. Securities not due at a single date are allocated based on weighted average life.
14 | ||||||||
Mortgage Loans
The following table presents the amortized cost basis of mortgage loans for each credit quality indicator by year of origination. The primary credit quality indicators utilized are debt service coverage ratios (“DSCR”) and loan-to-value (“LTV”) ratios.
Mortgage Loans Amortized Cost Basis by Origination Year (a) | |||||||||||||||||||||||||||||||||||||||||
As of March 31, 2026 | 2026 | 2025 | 2024 | 2023 | 2022 | Prior | Total | ||||||||||||||||||||||||||||||||||
| (In millions) | |||||||||||||||||||||||||||||||||||||||||
| DSCR ≥1.6x | |||||||||||||||||||||||||||||||||||||||||
| LTV less than 55% | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||
| LTV 55% to 65% | $ | ||||||||||||||||||||||||||||||||||||||||
| LTV greater than 65% | |||||||||||||||||||||||||||||||||||||||||
| DSCR 1.2x - 1.6x | |||||||||||||||||||||||||||||||||||||||||
| LTV less than 55% | $ | $ | |||||||||||||||||||||||||||||||||||||||
| LTV 55% to 65% | |||||||||||||||||||||||||||||||||||||||||
| LTV greater than 65% | |||||||||||||||||||||||||||||||||||||||||
| DSCR ≤1.2x | |||||||||||||||||||||||||||||||||||||||||
| LTV less than 55% | |||||||||||||||||||||||||||||||||||||||||
| LTV 55% to 65% | |||||||||||||||||||||||||||||||||||||||||
| LTV greater than 65% | |||||||||||||||||||||||||||||||||||||||||
| Total | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||
| (a) | The values in the table above reflect DSCR on a standardized amortization period and LTV ratios based on the most recent appraised values trended forward using changes in a commercial real estate price index. | ||||
Investment Commitments
15 | ||||||||
3. Fair Value
Assets and liabilities measured at fair value on a recurring basis are summarized in the following tables. Corporate bonds and other includes obligations of the United States of America (“U.S.”) Treasury, government-sponsored enterprises, foreign governments and redeemable preferred stock.
| March 31, 2026 | Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||
| (In millions) | |||||||||||||||||||||||
| Fixed maturity securities: | |||||||||||||||||||||||
| Corporate bonds and other | $ | $ | $ | $ | |||||||||||||||||||
| States, municipalities and political subdivisions | |||||||||||||||||||||||
| Asset-backed | |||||||||||||||||||||||
| Fixed maturities available-for-sale | |||||||||||||||||||||||
| Fixed maturities trading | |||||||||||||||||||||||
| Total fixed maturities | $ | $ | $ | $ | |||||||||||||||||||
| Equity securities | $ | $ | $ | $ | |||||||||||||||||||
| Short-term and other | |||||||||||||||||||||||
| Payable to brokers | ( | ( | |||||||||||||||||||||
| December 31, 2025 | |||||||||||||||||||||||
| Fixed maturity securities: | |||||||||||||||||||||||
| Corporate bonds and other | $ | $ | $ | $ | |||||||||||||||||||
| States, municipalities and political subdivisions | |||||||||||||||||||||||
| Asset-backed | |||||||||||||||||||||||
| Fixed maturities available-for-sale | |||||||||||||||||||||||
| Fixed maturities trading | |||||||||||||||||||||||
| Total fixed maturities | $ | $ | $ | $ | |||||||||||||||||||
| Equity securities | $ | $ | $ | $ | |||||||||||||||||||
| Short-term and other | |||||||||||||||||||||||
| Payable to brokers | ( | ( | |||||||||||||||||||||
16 | ||||||||
The following tables present reconciliations for all assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) for the three months ended March 31, 2026 and 2025:
| Net Realized Investment Gains (Losses) and Net Change in Unrealized Investment Gains (Losses) | Unrealized Gains (Losses) Recognized in Net Income (Loss) on Level 3 Assets and Liabilities Held at March 31 | Unrealized Gains (Losses) Recognized in Other Comprehensive Income (Loss) on Level 3 Assets and Liabilities Held at March 31 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2026 | Balance, January 1 | Included in Net Income | Included in OCI | Purchases | Sales | Settlements | Transfers into Level 3 | Transfers out of Level 3 | Balance, March 31 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| (In millions) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fixed maturity securities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Corporate bonds and other | $ | $ | ( | $ | ( | $ | $ | ( | $ | $ | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| States, municipalities and political subdivisions | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Asset-backed | ( | ( | $ | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fixed maturities available-for-sale | $ | $ | ( | $ | ( | $ | $ | $ | ( | $ | $ | ( | $ | $ | $ | ( | |||||||||||||||||||||||||||||||||||||||||||||||||
| Equity securities | $ | $ | ( | $ | $ | ( | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fixed maturity securities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Corporate bonds and other | $ | $ | $ | $ | ( | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| States, municipalities and political subdivisions | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Asset-backed | $ | ( | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fixed maturities available-for-sale | $ | $ | $ | $ | $ | $ | ( | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity securities | $ | $ | $ | ( | $ | $ | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
17 | ||||||||
Net investment gains and losses are reported in Net income as follows:
| Category of Assets and Liabilities | Consolidated Condensed Statements of Operations Line Items | ||||
| Fixed maturity securities available-for-sale | Investment gains (losses) | ||||
| Fixed maturity securities trading | Net investment income | ||||
| Equity securities | Investment gains (losses) and Net investment income | ||||
| Other invested assets | Investment gains (losses) and Net investment income | ||||
| Derivative financial instruments held in a trading portfolio | Net investment income | ||||
| Derivative financial instruments, other | Investment gains (losses) and Operating revenues and other | ||||
Significant Unobservable Inputs
The following tables present quantitative information about the significant unobservable inputs utilized in the fair value measurement of Level 3 assets. Valuations for assets and liabilities not presented in the tables below are primarily based on broker/dealer quotes for which there is a lack of transparency as to inputs used to develop the valuations. The quantitative detail of unobservable inputs from these broker quotes is neither provided nor reasonably available. The weighted average rate is calculated based on fair value.
| March 31, 2026 | Estimated Fair Value | Valuation Techniques | Unobservable Inputs | Range (Weighted Average) | ||||||||||||||||||||||||||||
| (In millions) | ||||||||||||||||||||||||||||||||
| Fixed maturity securities | $ | % | — | % | ( | %) | ||||||||||||||||||||||||||
| December 31, 2025 | ||||||||||||||||||||||||||||||||
| Fixed maturity securities | $ | % | — | % | ( | %) | ||||||||||||||||||||||||||
For fixed maturity securities, an increase to the credit spread assumptions would result in a lower fair value measurement.
Financial Assets and Liabilities Not Measured at Fair Value
The carrying amount, estimated fair value and the level of the fair value hierarchy of the financial assets and liabilities which are not measured at fair value on the Consolidated Condensed Balance Sheets are presented in the following tables. The carrying amounts and estimated fair values of short-term debt and long-term debt exclude finance lease obligations. The carrying amounts reported on the Consolidated Condensed Balance Sheets for cash and short-term investments not carried at fair value and certain other assets and liabilities approximate fair value due to the short-term nature of these items.
18 | ||||||||
| Carrying Amount | Estimated Fair Value | ||||||||||||||||||||||||||||
| March 31, 2026 | Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||||||||
| (In millions) | |||||||||||||||||||||||||||||
| Assets: | |||||||||||||||||||||||||||||
| Other invested assets, primarily mortgage loans | $ | $ | $ | ||||||||||||||||||||||||||
| Liabilities: | |||||||||||||||||||||||||||||
| Short-term debt | |||||||||||||||||||||||||||||
| Long-term debt | $ | ||||||||||||||||||||||||||||
| December 31, 2025 | |||||||||||||||||||||||||||||
| Assets: | |||||||||||||||||||||||||||||
| Other invested assets, primarily mortgage loans | $ | $ | $ | ||||||||||||||||||||||||||
| Liabilities: | |||||||||||||||||||||||||||||
| Short-term debt | $ | ||||||||||||||||||||||||||||
| Long-term debt | |||||||||||||||||||||||||||||
4. Claim and Claim Adjustment Expense Reserves
Claim and claim adjustment expense reserves represent the estimated amounts necessary to resolve all outstanding claims, including incurred but not reported (“IBNR”) claims as of the reporting date. Reserve projections are based primarily on detailed analysis of the facts in each case, experience with similar cases and various historical development patterns. Consideration is given to historical patterns such as claim reserving trends and settlement practices, loss payments, pending levels of unpaid claims and product mix, economic, medical and social inflation, and public attitudes. All of these factors can affect the estimation of claim and claim adjustment expense reserves.
Establishing claim and claim adjustment expense reserves, including claim and claim adjustment expense reserves for catastrophic events that have occurred, is an estimation process. Many factors can ultimately affect the final settlement of a claim and, therefore, the necessary reserve. Changes in the law, results of litigation, medical costs, the cost of repair materials and labor rates can affect ultimate claim costs. In addition, time can be a critical part of reserving determinations since the longer the span between the incidence of a loss and the payment or settlement of the claim, the more variable the ultimate settlement amount can be. Accordingly, short-tail claims, such as property damage claims, tend to be more reasonably estimable than long-tail claims, such as workers’ compensation, general liability and professional liability claims. Claim and claim adjustment expense reserves are also maintained for structured settlement obligations. In developing the claim and claim adjustment expense reserve estimates for structured settlement obligations, actuaries review mortality experience on an annual basis. Adjustments to prior year reserve estimates, if necessary, are reflected in the results of operations in the period that the need for such adjustments is determined. There can be no assurance that the ultimate cost for insurance losses will not exceed current estimates.
Catastrophes are an inherent risk of the property and casualty insurance business and have contributed to material period-to-period fluctuations in the Company’s results of operations and/or equity. Catastrophe-related reinstatement premiums represent additional consideration paid under certain reinsurance agreements to reinstate coverage limits that have been exhausted as a result of losses. Catastrophe losses, net of reinsurance, of $88 million and catastrophe-related reinsurance reinstatement premiums of $9 million were recorded for the three months ended March 31, 2026, driven by severe weather-related events. Catastrophe losses, net of reinsurance, of $97 million were recorded for the three months ended March 31, 2025, driven by severe weather-related events, including $53 million for the California wildfires. There were no catastrophe-related reinsurance reinstatement premiums for the three months ended March 31, 2025.
19 | ||||||||
Liability for Unpaid Claim and Claim Adjustment Expenses
The following table presents a reconciliation between beginning and ending claim and claim adjustment expense reserves.
Three Months Ended March 31 | 2026 | 2025 | |||||||||||||||
| (In millions) | |||||||||||||||||
| Reserves, beginning of year: | |||||||||||||||||
| Gross | $ | $ | |||||||||||||||
| Ceded | |||||||||||||||||
| Net reserves, beginning of year | |||||||||||||||||
| Net incurred claim and claim adjustment expenses: | |||||||||||||||||
| Provision for insured events of current year | |||||||||||||||||
| Increase (decrease) in provision for insured events of prior years | |||||||||||||||||
| Amortization of discount | |||||||||||||||||
Total net incurred (a) | |||||||||||||||||
| Net payments attributable to: | |||||||||||||||||
| Current year events | ( | ( | |||||||||||||||
| Prior year events | ( | ( | |||||||||||||||
| Total net payments | ( | ( | |||||||||||||||
| Foreign currency translation adjustment and other | ( | ||||||||||||||||
| Net reserves, end of period | |||||||||||||||||
| Ceded reserves, end of period | |||||||||||||||||
| Gross reserves, end of period | $ | $ | |||||||||||||||
| (a) | Total net incurred does not agree to Insurance claims and policyholders’ benefits as reflected on the Consolidated Condensed Statements of Operations due to amounts related to retroactive reinsurance deferred gain accounting, uncollectible reinsurance and benefit expenses related to future policy benefits and policyholders’ dividends, which are not reflected in the table above. | ||||
Net Prior Year Development
Changes in estimates of claim and claim adjustment expense reserves, net of reinsurance, for prior years are defined as net prior year loss reserve development. These changes can be favorable or unfavorable.
Unfavorable net prior year loss reserve development of $100 million and $61 million for the three months ended March 31, 2026 and 2025 was recorded for CNA’s commercial property and casualty operations (“Property & Casualty Operations”). No net prior year loss reserve development and unfavorable net prior year loss reserve development of $22 million for the three months ended March 31, 2026 and 2025 was recorded for CNA’s operations outside of Property & Casualty Operations (“Other Insurance Operations”).
20 | ||||||||
The following table and discussion present details of the net prior year loss reserve development in Property & Casualty Operations and Other Insurance Operations:
| Three Months Ended March 31 | 2026 | 2025 | ||||||||||||||||||||||||
| (In millions) | ||||||||||||||||||||||||||
| Other professional liability and management liability | $ | |||||||||||||||||||||||||
| Warranty | $ | |||||||||||||||||||||||||
| Commercial auto | ||||||||||||||||||||||||||
| General liability | ||||||||||||||||||||||||||
| Workers’ compensation | ||||||||||||||||||||||||||
| Total property & casualty operations | ||||||||||||||||||||||||||
| Other insurance operations | ||||||||||||||||||||||||||
| Total pretax unfavorable development | $ | $ | ||||||||||||||||||||||||
2026
Unfavorable development in other professional liability and management liability was primarily due to higher than expected claim severity and frequency in CNA’s professional errors and omissions (“E&O”) business in recent accident years.
Unfavorable development in general liability was due to higher than expected claim severity and frequency in the excess casualty line in recent accident years.
2025
Unfavorable development in warranty was primarily due to higher than expected frequency and severity in the most recent accident year for auto warranty.
Unfavorable development in commercial auto was due to higher than expected claim severity, largely in CNA’s construction business in the most recent accident year.
Unfavorable development in Other insurance operations was associated with legacy mass tort abuse claim activity.
Asbestos & Environmental Pollution (“A&EP”) Reserves
In 2010, Continental Casualty Company (“CCC”) together with several insurance subsidiaries completed a transaction with National Indemnity Company (“NICO”), a subsidiary of Berkshire Hathaway Inc., under which substantially all of their legacy A&EP liabilities were ceded to NICO through a loss portfolio transfer (“LPT”). At the effective date of the transaction, approximately $1.6 billion of net A&EP claim and allocated claim adjustment expense reserves were ceded to NICO under a retroactive reinsurance agreement with an aggregate limit of $4.0 billion. The $1.6 billion of claim and allocated claim adjustment expense reserves ceded to NICO was net of $1.2 billion of ceded claim and allocated claim adjustment expense reserves under existing third party reinsurance contracts. The NICO LPT aggregate reinsurance limit also covers credit risk on the existing third party reinsurance related to these liabilities. NICO was paid a reinsurance premium of $2.0 billion and billed third party reinsurance receivables related to A&EP claims with a net book value of $215 million were transferred to NICO, resulting in total consideration of $2.2 billion.
In years subsequent to the effective date of the LPT, adverse prior year development on A&EP reserves was recognized resulting in additional amounts ceded under the LPT. As a result, the cumulative amounts ceded under the LPT have exceeded the $2.2 billion consideration paid, resulting in the NICO LPT moving into a gain position, requiring retroactive reinsurance accounting. Under retroactive reinsurance accounting, this gain is deferred and only recognized in earnings in proportion to actual paid recoveries under the LPT. Over the life of the contract, there is no economic impact as long as any additional losses incurred are within the limit of the LPT. In a period in which a change in the estimate of A&EP reserves is recognized that increases or decreases the amounts ceded under the LPT, the proportion of actual paid recoveries to total ceded losses is affected and the change in the deferred gain is recognized in earnings as if the revised estimate of ceded losses was available at the effective date of the LPT. The effect of the deferred retroactive reinsurance benefit is recorded in Insurance claims and policyholders’ benefits on the Consolidated Condensed Statements of Operations.
21 | ||||||||
The impact of the LPT on the Consolidated Condensed Statements of Operations was the recognition of a retroactive reinsurance benefit of $22 million and $17 million for the three months ended March 31, 2026 and 2025. As of March 31, 2026 and December 31, 2025, the cumulative amounts ceded under the LPT were $3.9 448 million and $470 million as of March 31, 2026 and December 31, 2025 and is included within Other liabilities on the Consolidated Condensed Balance Sheets.
NICO established a collateral trust account as security for its obligations under the LPT. The fair value of the collateral trust account was $2.6 billion as of March 31, 2026. In addition, Berkshire Hathaway Inc. guaranteed the payment obligations of NICO up to the aggregate reinsurance limit as well as certain of NICO’s performance obligations under the trust agreement. NICO is responsible for claims handling and billing and collection from third-party reinsurers related to A&EP claims.
Credit Risk for Ceded Reserves
The majority of CNA’s outstanding voluntary reinsurance receivables are due from reinsurers with financial strength ratings of A- or higher. Receivables due from reinsurers with lower financial strength ratings are primarily due from captive reinsurers and are backed by collateral arrangements.
5. Future Policy Benefits Reserves
Future policy benefits reserves are associated with CNA’s run-off long-term care business, which is included in Other Insurance Operations, and relate to policyholders that are currently receiving benefits, including claims that have been incurred but are not yet reported, as well as policyholders that are not yet receiving benefits. Future policy benefits reserves are comprised of the liability for future policyholder benefits (“LFPB”) which is reflected as Insurance reserves: Future policy benefits on the Consolidated Condensed Balance Sheets.
The determination of Future policy benefits reserves requires management to make estimates and assumptions about expected policyholder experience over the remaining life of the policy. Since policies may be in force for several decades, these assumptions are subject to significant estimation risk. As a result of this variability, CNA’s future policy benefits reserves may be subject to material increases if actual experience develops adversely to its expectations.
For further information on the long-term care reserving process see Note 1 of the Consolidated Financial Statements in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025.
22 | ||||||||
The following table summarizes balances and changes in the LFPB:
| 2026 | 2025 | ||||||||||
| (In millions) | |||||||||||
| Present value of future net premiums | |||||||||||
| Balance, January 1 | $ | $ | |||||||||
| Effect of changes in discount rate | ( | ( | |||||||||
| Balance, January 1, at original locked in discount rate | |||||||||||
| Effect of changes in cash flow assumptions (a) | |||||||||||
| Effect of actual variances from expected experience (a) | |||||||||||
| Adjusted balance, January 1 | |||||||||||
| Interest accrual | |||||||||||
| Net premiums: earned during period | ( | ( | |||||||||
| Balance, end of period at original locked in discount rate | |||||||||||
| Effect of changes in discount rate | |||||||||||
Balance, March 31 | $ | $ | |||||||||
| Present value of future benefits & expenses | |||||||||||
| Balance, January 1 | $ | $ | |||||||||
| Effect of changes in discount rate | |||||||||||
| Balance, January 1, at original locked in discount rate | |||||||||||
| Effect of changes in cash flow assumptions (a) | |||||||||||
| Effect of actual variances from expected experience (a) | |||||||||||
| Adjusted balance, January 1 | |||||||||||
| Interest accrual | |||||||||||
| Benefit & expense payments | ( | ( | |||||||||
| Balance, end of period at original locked in discount rate | |||||||||||
| Effect of changes in discount rate | ( | ( | |||||||||
Balance, March 31 | $ | $ | |||||||||
Net LFPB, March 31 | $ | $ | |||||||||
| (a) | As of March 31, 2026 and 2025, the re-measurement loss of $ | ||||
23 | ||||||||
The following table presents earned premiums and interest accretion associated with the long-term care business recognized on the Condensed Consolidated Statement of Operations.
| Three Months Ended March 31 | 2026 | 2025 | ||||||||||||||||||
| (In millions) | ||||||||||||||||||||
| Earned premiums | $ | $ | ||||||||||||||||||
| Interest accretion | ||||||||||||||||||||
The following table presents undiscounted expected future benefit and expense payments and undiscounted expected future gross premiums.
| March 31, | |||||||||||
| 2026 | 2025 | ||||||||||
| (In millions) | |||||||||||
| Expected future benefit and expense payments | $ | $ | |||||||||
| Expected future gross premiums | |||||||||||
Discounted expected future gross premiums at the upper-medium grade fixed income instrument yield discount rate were $3.4 billion and $3.6 billion as of March 31, 2026 and 2025.
The weighted average effective duration of the LFPB calculated using the original locked in discount rate was 11
The weighted average interest rates in the table below are calculated based on the rate used to discount all future cash flows.
| March 31, | December 31, | ||||||||||||||||
| 2026 | 2025 | 2025 | |||||||||||||||
| Original locked in discount rate | % | % | % | ||||||||||||||
| Upper-medium grade fixed income instrument discount rate | |||||||||||||||||
24 | ||||||||
6. Shareholders’ Equity
Accumulated other comprehensive income (loss)
The tables below present the changes in Accumulated other comprehensive income (loss) (“AOCI”) by component for the three months ended March 31, 2025 and 2026:
| Net Unrealized Gains (Losses) on Investments with an Allowance for Credit Losses | Net Unrealized Gains (Losses) on Other Investments | Cumulative impact of changes in discount rates used to measure long duration contracts | Unrealized Gains (Losses) on Cash Flow Hedges | Pension and Postretirement Benefits | Foreign Currency Translation | Total Accumulated Other Comprehensive Income (Loss) | |||||||||||||||||||||||||||||||||||
| (In millions) | |||||||||||||||||||||||||||||||||||||||||
Balance, January 1, 2025 | $ | ( | $ | ( | $ | $ | $ | ( | $ | ( | $ | ( | |||||||||||||||||||||||||||||
Other comprehensive income (loss) before reclassifications, after tax of $ | ( | ( | ( | ( | |||||||||||||||||||||||||||||||||||||
Reclassification of losses from accumulated other comprehensive loss, after tax of $ | |||||||||||||||||||||||||||||||||||||||||
| Other comprehensive income (loss) | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||
| Amounts attributable to noncontrolling interests | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||
| Other | ( | ( | |||||||||||||||||||||||||||||||||||||||
Balance, March 31, 2025 | $ | ( | $ | ( | $ | $ | $ | ( | $ | ( | $ | ( | |||||||||||||||||||||||||||||
Balance, January 1, 2026 | $ | ( | $ | ( | $ | $ | $ | ( | $ | ( | $ | ( | |||||||||||||||||||||||||||||
Other comprehensive income (loss) before reclassifications, after tax of $ | ( | ( | ( | ( | ( | ||||||||||||||||||||||||||||||||||||
Reclassification of losses from accumulated other comprehensive loss, after tax of $( | |||||||||||||||||||||||||||||||||||||||||
| Other comprehensive income (loss) | ( | ( | ( | ( | |||||||||||||||||||||||||||||||||||||
| Amounts attributable to noncontrolling interests | ( | ||||||||||||||||||||||||||||||||||||||||
Balance, March 31, 2026 | $ | ( | $ | ( | $ | $ | $ | ( | $ | ( | $ | ( | |||||||||||||||||||||||||||||
Amounts reclassified from AOCI shown above are reported in Net income (loss) as follows:
| Major Category of AOCI | Affected Line Item | ||||
| Net unrealized gains (losses) on investments with an allowance for credit losses and Net unrealized gains (losses) on other investments | Investment gains (losses) | ||||
| Unrealized gains (losses) on cash flow hedges | Operating revenues and other, Interest expense and Operating expenses and other | ||||
| Pension and postretirement benefits | Operating expenses and other | ||||
25 | ||||||||
Stock Purchases
Loews Corporation repurchased 0.3 million and 4.5 million shares of its common stock at aggregate costs of $31 million and $380 million during the three months ended March 31, 2026 and 2025.
Stock Issuances
Loews Corporation issued 0.1
7. Debt
In February of 2026, Loews Corporation completed a public offering of $500 million aggregate principal amount of 4.9 % senior notes due April 1, 2036, the proceeds of which were used to redeem on March 19, 2026 the outstanding $500 million aggregate principal amount of its 3.8 % senior notes due April 1, 2026.
In March of 2026, Boardwalk Pipelines redeemed the outstanding $550 million aggregate principal amount of its 6.0 % senior notes due June 1, 2026.
8. Revenue from Contracts with Customers
Disaggregation of revenues – Revenue from contracts with customers, other than insurance premiums, is reported as Non-insurance warranty revenue and within Operating revenues and other on the Consolidated Condensed Statements of Operations. The following table presents revenues from contracts with customers disaggregated by revenue type along with the reportable segment and a reconciliation to Operating revenues and other as reported in Note 12:
| Three Months Ended March 31 | 2026 | 2025 | ||||||||||||||||||||||||
| (In millions) | ||||||||||||||||||||||||||
| Non-insurance warranty – CNA Financial | $ | $ | ||||||||||||||||||||||||
| Transportation and storage of natural gas and NGLs and ethane supply and transportation services – Boardwalk Pipelines | $ | $ | ||||||||||||||||||||||||
| Lodging and related services – Loews Hotels & Co | ||||||||||||||||||||||||||
| Total revenues from contracts with customers | ||||||||||||||||||||||||||
| Other revenues | ||||||||||||||||||||||||||
| Operating revenues and other | $ | $ | ||||||||||||||||||||||||
Receivables from contracts with customers – As of March 31, 2026 and December 31, 2025, receivables from contracts with customers were approximately $253 million and $252 million and are included within Receivables on the Consolidated Condensed Balance Sheets.
Deferred revenue – As of March 31, 2026 and December 31, 2025, deferred revenue resulting from contracts with customers was approximately $4.1 billion and $4.2 billion and is reported as Deferred non-insurance warranty revenue and within Other liabilities on the Consolidated Condensed Balance Sheets. Approximately $397 million and $413 million of revenues recognized during the three months ended March 31, 2026 and 2025 were included in deferred revenue as of December 31, 2025 and 2024.
Performance obligations – As of March 31, 2026, approximately $23.7 billion of estimated operating revenues is expected to be recognized in the future related to outstanding performance obligations. The balance relates primarily to revenues for transportation and storage services for natural gas and natural gas liquids, olefins and other hydrocarbons (“NGLs”) and certain ethane supply contracts at Boardwalk Pipelines and non-insurance warranty revenue at CNA. Included in the balance are $9.5 billion of revenues that are anticipated under executed precedent or long-term firm transportation agreements associated with Boardwalk Pipelines’ growth projects. Approximately $2.3 billion is expected to be recognized during the remaining nine months of 2026, $2.5 billion in 2027 and the remainder in following years. The actual timing of recognition may vary due to factors outside of the Company’s control.
26 | ||||||||
9. Benefit Plans
Several non-contributory defined benefit plans and postretirement benefit plans cover eligible employees and retirees.
The following table presents the components of net periodic (benefit) cost for the defined benefit plans:
Pension Benefits | Other Postretirement Benefits | ||||||||||||||||||||||||||||
| Three Months Ended March 31 | 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||||||||
| (In millions) | |||||||||||||||||||||||||||||
| Service cost | $ | ||||||||||||||||||||||||||||
| Interest cost | $ | $ | $ | ||||||||||||||||||||||||||
| Expected return on plan assets | ( | ( | ( | ( | |||||||||||||||||||||||||
| Amortization of unrecognized net loss | |||||||||||||||||||||||||||||
| Net periodic benefit | $ | ( | $ | ( | $ | $ | |||||||||||||||||||||||
CNA sponsors a noncontributory defined benefit pension plan, the CNA Retirement Plan (the “Plan”), covering certain eligible employees. The Plan has been closed to new entrants since 2000. In the first quarter of 2026, a subsidiary of CNA, as sponsor of the Plan, approved the decision to pursue termination of the Plan, effective June 30, 2026. The Plan will continue to be reflected in the consolidated condensed financial statements until the termination process, including the settlement or transfer of remaining benefit obligations, has been completed, which CNA currently anticipates will be in approximately 18 months.
10. Legal Proceedings
Loews Hotels & Co
On February 20, 2024, Jeanette Portillo and other plaintiffs filed a putative class action against Loews Hotels Holdings Corporation and other defendants in the United States District Court for the Western District of Washington asserting antitrust claims against defendants under the Sherman Act, 15 U.S.C. § 1. Defendants jointly filed a motion to dismiss the complaint in Portillo on May 17, 2024. On August 29, 2025, the court granted the defendants’ motion to dismiss in Portillo and granted plaintiffs leave to amend their complaint. On October 3, 2025, plaintiffs in Portillo filed an amended class action complaint, which defendants jointly moved to dismiss on November 3, 2025. The court has not ruled on the motion to dismiss the amended complaint in Portillo. On March 1, 2024, Ryan Segal filed a putative class action against Loews Hotels Holdings Corporation and other defendants in the United States District Court for the Northern District of Illinois asserting antitrust claims against defendants under the Sherman Act, 15 U.S.C. § 1. Defendants jointly filed a motion to dismiss the complaint in Segal on June 24, 2024. On March 31, 2025, the court granted the defendants’ motion to dismiss in Segal, and granted plaintiff leave to amend the complaint. On April 28, 2025, Segal filed a third amended complaint, which defendants jointly moved to dismiss on June 12, 2025. On March 31, 2026, the court granted defendants’ motion to dismiss the third amended complaint in Segal with prejudice and entered judgment. On April 29, 2026, Segal filed a notice of appeal to the United States Court of Appeals for the Seventh Circuit of the district court’s March 31, 2026 order granting defendants’ motion to dismiss the third amended complaint.
Boardwalk Pipelines Litigation
On May 25, 2018, plaintiffs Tsemach Mishal and Paul Berger (on behalf of themselves and the purported class, “Plaintiffs”) initiated a purported class action in the Court of Chancery of the State of Delaware (the “Trial Court”) against the following defendants: Boardwalk Pipelines, Boardwalk GP, LP (“General Partner”), Boardwalk GP, LLC and Boardwalk Pipelines Holding Corp. (“BPHC”) (together, “Defendants”), regarding the potential exercise by the General Partner of its right to purchase all of the issued and outstanding common units representing limited partnership interests in Boardwalk Pipelines not already owned by the General Partner or its affiliates.
On June 25, 2018, Plaintiffs and Defendants entered into a Stipulation and Agreement of Compromise and Settlement, subject to the approval of the Trial Court (the “Proposed Settlement”). Under the terms of the Proposed Settlement, the lawsuit would be dismissed, and related claims against the Defendants would be released by the Plaintiffs, if BPHC, the sole member of the General Partner, elected to cause the General Partner to exercise its right to purchase the issued and outstanding common units of Boardwalk Pipelines pursuant to Boardwalk Pipelines’ Third Amended and Restated
27 | ||||||||
Agreement of Limited Partnership, as amended (“Limited Partnership Agreement”), within a period specified by the Proposed Settlement. On June 29, 2018, the General Partner elected to exercise its right to purchase all of the issued and outstanding common units representing limited partnership interests in Boardwalk Pipelines not already owned by the General Partner or its affiliates pursuant to the Limited Partnership Agreement within the period specified by the Proposed Settlement. The transaction was completed on July 18, 2018.
On September 28, 2018, the Trial Court denied approval of the Proposed Settlement. On February 11, 2019, a substitute verified class action complaint was filed in this proceeding, which among other things, added the Parent Company as a Defendant. The Defendants filed a motion to dismiss, which was heard by the Trial Court in July of 2019. In October of 2019, the Trial Court ruled on the motion and granted a partial dismissal, with certain aspects of the case proceeding to trial. A trial was held the week of February 22, 2021 and post-trial oral arguments were held on July 14, 2021.
On November 12, 2021, the Trial Court issued a ruling in the case. The Trial Court held that the General Partner breached the Limited Partnership Agreement and awarded Plaintiffs approximately $690 million, plus pre-judgment interest (approximately $166 million), post-judgment interest and attorneys’ fees.
The Company believed that the Trial Court ruling included factual and legal errors. Therefore, on January 3, 2022, the Defendants appealed the Trial Court’s ruling to the Supreme Court of the State of Delaware (the “Supreme Court”). On January 17, 2022, the Plaintiffs filed a cross-appeal to the Supreme Court contesting the calculation of damages by the Trial Court. Oral arguments were held on September 14, 2022, and on December 19, 2022, the Supreme Court reversed the Trial Court’s ruling and remanded the case to the Trial Court for further proceedings related to claims not decided by the Trial Court’s ruling. Briefing by the parties at the Trial Court on the remanded issues was completed in September 2023. A hearing on the remanded issues was held at the Trial Court in April 2024. In September 2024, the Trial Court ruled in favor of the Defendants on all of the remanded issues.
On October 21, 2024, the Plaintiffs appealed the Trial Court’s ruling on the remanded issues to the Supreme Court. Briefing on this appeal was completed in March 2025 and a hearing on this appeal occurred in June 2025. On December 10, 2025, the Supreme Court affirmed in part and reversed in part the Trial Court’s ruling. In its decision the Supreme Court found that the General Partner had breached the Limited Partnership Agreement in its exercise of the Purchase Right. In its 2022 decision, the Supreme Court had previously determined that the General Partner was exculpated from damages. The remaining claims that have been remanded by the Supreme Court to the Trial Court for further proceedings are tortious interference and unjust enrichment claims related to the exercise of the Purchase Right against the non-General Partner defendants.
Litigation is inherently uncertain, and the ultimate outcome of this matter cannot be predicted with certainty. Based on currently available information, the Company is unable to reasonably estimate the amount of loss or range of loss, if any, associated with this matter. Accordingly, no accrual has been recorded. Although the Company is unable to estimate the amount of loss or range of loss at this time, it is possible that the resolution of this matter could be material to the Company’s consolidated financial position, results of operations and/or cash flows in a particular period. The Company will continue to evaluate developments in this matter and will record an accrual if it is determined that a loss is probable and reasonably estimable.
Other Litigation
11. Commitments and Contingencies
CNA Guarantees
CNA has provided guarantees, if the primary obligor fails to perform, to holders of structured settlement annuities issued by a previously owned subsidiary. As of March 31, 2026, the potential amount of future payments CNA could be required to pay under these guarantees was approximately $1.9 billion, which will be paid over the lifetime of the annuitants. CNA does not believe any payment is likely under these guarantees, as CNA is the beneficiary of a trust that must be maintained at a level that approximates the discounted reserves for these annuities.
28 | ||||||||
Boardwalk Pipelines
Boardwalk Pipelines’ future capital commitments are comprised of binding commitments under purchase orders for materials ordered but not received. As of March 31, 2026, the commitments totaled approximately $467 million, which are expected to be settled through 2028.
12. Segments
Loews Corporation has four reportable segments comprised of three individual consolidated operating subsidiaries, CNA, Boardwalk Pipelines and Loews Hotels & Co; and the Corporate segment. The Corporate segment is comprised of Loews Corporation, excluding its consolidated subsidiaries, and includes the equity method of accounting for Altium Packaging. Each of the operating subsidiaries is headed by a chief executive officer who is responsible for the operation of its business and has the duties and authority commensurate with that position. For additional disclosures regarding Loews Corporation’s segments, see Note 19 of the Consolidated Financial Statements in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025.
The following tables present the reportable segments and their contribution to the Consolidated Condensed Statements of Operations. Amounts presented will not necessarily be the same as those in the individual financial statements of the subsidiaries due to adjustments for purchase accounting, income taxes and noncontrolling interests.
29 | ||||||||
Statements of Operations by segment are presented in the following tables.
| Three Months Ended March 31, 2026 | CNA Financial | Boardwalk Pipelines | Loews Hotels & Co | Corporate | Total | ||||||||||||||||||||||||||||||
| (In millions) | |||||||||||||||||||||||||||||||||||
| Revenues: | |||||||||||||||||||||||||||||||||||
| Insurance premiums | $ | $ | ( | $ | |||||||||||||||||||||||||||||||
| Net investment income (loss) | $ | $ | ( | ||||||||||||||||||||||||||||||||
| Investment losses | ( | ( | |||||||||||||||||||||||||||||||||
| Non-insurance warranty revenue | |||||||||||||||||||||||||||||||||||
| Operating revenues and other | |||||||||||||||||||||||||||||||||||
| Total | $ | ( | |||||||||||||||||||||||||||||||||
| Expenses: | |||||||||||||||||||||||||||||||||||
| Insurance claims and policyholders’ benefits (a) | |||||||||||||||||||||||||||||||||||
| Amortization of deferred acquisition costs | |||||||||||||||||||||||||||||||||||
| Non-insurance warranty expense | |||||||||||||||||||||||||||||||||||
| Operating expenses and other (b) | |||||||||||||||||||||||||||||||||||
| Equity method (income) loss | ( | ( | |||||||||||||||||||||||||||||||||
| Interest | |||||||||||||||||||||||||||||||||||
| Total | |||||||||||||||||||||||||||||||||||
| Income (loss) before income tax | ( | ||||||||||||||||||||||||||||||||||
| Income tax (expense) benefit | ( | ( | ( | ( | |||||||||||||||||||||||||||||||
| Net income (loss) | ( | ||||||||||||||||||||||||||||||||||
| Amounts attributable to noncontrolling interests | ( | ( | |||||||||||||||||||||||||||||||||
| Net income (loss) attributable to Loews Corporation | $ | $ | $ | $ | ( | $ | |||||||||||||||||||||||||||||
| March 31, 2026 | |||||||||||||||||||||||||||||||||||
| Total assets | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||
| (a) | Significant segment expenses within Insurance claims and policyholders’ benefits include catastrophe losses of $ | ||||
30 | ||||||||
| (b) | Significant segment expenses included in Operating expenses and other: | ||||
| Three Months Ended March 31, 2026 | CNA Financial | Boardwalk Pipelines | Loews Hotels & Co | Corporate | Total | ||||||||||||||||||||||||||||||
| Insurance related administrative expenses | $ | $ | |||||||||||||||||||||||||||||||||
| Operating expenses | $ | $ | |||||||||||||||||||||||||||||||||
| Depreciation and amortization | $ | ||||||||||||||||||||||||||||||||||
| Other (c) | |||||||||||||||||||||||||||||||||||
| Operating expenses and other | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||
| (c) | Other expenses for each reportable segment include: | ||||
| CNA Financial: reflects expenses not directly related to insurance operations, which includes certain expenses related to its non-insurance warranty business and claims services offerings, as well as foreign currency transaction gains and losses. | |||||
| Boardwalk Pipelines: general and administrative expenses | |||||
| Loews Hotels & Co: general and administrative and reimbursable expenses | |||||
| Corporate: general and administrative expenses | |||||
31 | ||||||||
| Three Months Ended March 31, 2025 | CNA Financial | Boardwalk Pipelines | Loews Hotels & Co | Corporate | Total | ||||||||||||||||||||||||||||||
| (In millions) | |||||||||||||||||||||||||||||||||||
| Revenues: | |||||||||||||||||||||||||||||||||||
| Insurance premiums | $ | $ | |||||||||||||||||||||||||||||||||
| Net investment income | $ | $ | |||||||||||||||||||||||||||||||||
| Investment losses | ( | ( | |||||||||||||||||||||||||||||||||
| Non-insurance warranty revenue | |||||||||||||||||||||||||||||||||||
| Operating revenues and other | |||||||||||||||||||||||||||||||||||
| Total | $ | ||||||||||||||||||||||||||||||||||
| Expenses: | |||||||||||||||||||||||||||||||||||
| Insurance claims and policyholders’ benefits (a) | |||||||||||||||||||||||||||||||||||
| Amortization of deferred acquisition costs | |||||||||||||||||||||||||||||||||||
| Non-insurance warranty expense | |||||||||||||||||||||||||||||||||||
| Operating expenses and other (b) | |||||||||||||||||||||||||||||||||||
| Equity method (income) loss | ( | ||||||||||||||||||||||||||||||||||
| Interest | |||||||||||||||||||||||||||||||||||
| Total | |||||||||||||||||||||||||||||||||||
| Income (loss) before income tax | ( | ||||||||||||||||||||||||||||||||||
| Income tax (expense) benefit | ( | ( | ( | ( | |||||||||||||||||||||||||||||||
| Net income (loss) | ( | ||||||||||||||||||||||||||||||||||
| Amounts attributable to noncontrolling interests | ( | ( | |||||||||||||||||||||||||||||||||
| Net income (loss) attributable to Loews Corporation | $ | $ | $ | $ | ( | $ | |||||||||||||||||||||||||||||
| March 31, 2025 | |||||||||||||||||||||||||||||||||||
| Total assets | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||
| (a) | Significant segment expenses within Insurance claims and policyholders’ benefits include catastrophe losses of $ | ||||
32 | ||||||||
| (b) | Significant segment expenses included in Operating expenses and other: | ||||
| Three Months Ended March 31, 2025 | CNA Financial | Boardwalk Pipelines | Loews Hotels & Co | Corporate | Total | ||||||||||||||||||||||||||||||
| Insurance related administrative expenses | $ | $ | |||||||||||||||||||||||||||||||||
| Operating expenses | $ | $ | |||||||||||||||||||||||||||||||||
| Depreciation and amortization | $ | ||||||||||||||||||||||||||||||||||
| Other (c) | |||||||||||||||||||||||||||||||||||
| Operating expenses and other | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||
| (c) | Other expenses for each reportable segment include: | ||||
| CNA Financial: reflects expenses not directly related to insurance operations, which includes certain expenses related to its non-insurance warranty business and claims services offerings, as well as foreign currency transaction gains and losses. | |||||
| Boardwalk Pipelines: general and administrative expenses | |||||
| Loews Hotels & Co: general and administrative and reimbursable expenses | |||||
| Corporate: general and administrative expenses | |||||
33 | ||||||||
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
Management’s discussion and analysis of financial condition and results of operations (“MD&A”) should be read in conjunction with our Consolidated Condensed Financial Statements included under Item 1 of this Report and the Consolidated Financial Statements, Risk Factors, and MD&A included in our Annual Report on Form 10-K for the year ended December 31, 2025. This MD&A is comprised of the following sections:
Page No. | |||||
OVERVIEW
Loews Corporation is a holding company and has four reportable segments comprised of three individual consolidated operating subsidiaries, CNA Financial Corporation (“CNA”), Boardwalk Pipeline Partners, LP (“Boardwalk Pipelines”) and Loews Hotels Holding Corporation (“Loews Hotels & Co”); and the Corporate segment. The Corporate segment is primarily comprised of Loews Corporation, excluding its consolidated operating subsidiaries, and the equity method of accounting for Altium Packaging LLC (“Altium Packaging”), an unconsolidated subsidiary.
Unless the context otherwise requires, as used herein, the term “Company” means Loews Corporation including its subsidiaries, the terms “Parent Company,” “we,” “our,” “us” or like terms mean Loews Corporation excluding its subsidiaries and the term “Net income (loss) attributable to Loews Corporation” means Net income (loss) attributable to Loews Corporation shareholders.
We rely upon our invested cash balances and distributions from our subsidiaries to generate the funds necessary to meet our obligations and to declare and pay any dividends to our shareholders. The ability of our subsidiaries to pay dividends is subject to, among other things, the availability of sufficient earnings and funds in such subsidiaries, applicable state laws, including in the case of the insurance subsidiaries of CNA, laws and rules governing the payment of dividends by regulated insurance companies (see Note 14 of the Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2025) and compliance with covenants in their respective loan agreements. Claims of creditors of our subsidiaries will generally have priority as to the assets of such subsidiaries over our claims and those of our creditors and shareholders. We are not responsible for the liabilities and obligations of our subsidiaries and there are no Parent Company guarantees.
34 | ||||||||
RESULTS OF OPERATIONS
Consolidated Financial Results
The following table summarizes net income (loss) attributable to Loews Corporation by segment and the basic and diluted net income per share attributable to Loews Corporation for the three months ended March 31, 2026 and 2025:
| Three Months Ended March 31 | 2026 | 2025 | ||||||||||||||||||
| (In millions, except per share data) | ||||||||||||||||||||
| CNA Financial | $ | 194 | $ | 252 | ||||||||||||||||
| Boardwalk Pipelines | 159 | 152 | ||||||||||||||||||
| Loews Hotels & Co | 26 | |||||||||||||||||||
| Corporate | (42) | (34) | ||||||||||||||||||
| Net income attributable to Loews Corporation | $ | 337 | $ | 370 | ||||||||||||||||
| Basic and diluted net income per share | $ | 1.63 | $ | 1.74 | ||||||||||||||||
Net income attributable to Loews Corporation for the three months ended March 31, 2026 was $337 million, or $1.63 per share, compared to net income of $370 million, or $1.74 per share in the comparable 2025 period.
The decrease in net income attributable to Loews Corporation for the three months ended March 31, 2026 as compared to the comparable 2025 period was primarily driven by lower net income at CNA and lower results at the parent company, partially offset by higher net income at Loews Hotels & Co and Boardwalk Pipelines. The decrease at CNA is primarily due to lower underlying underwriting results and unfavorable net prior year loss reserve development, partially offset by higher net investment income. Parent company results decreased primarily due to lower investment income from the parent company trading portfolio and higher interest expense. The increase at Loews Hotels & Co is primarily due to higher equity income from joint ventures, driven mainly by the Universal Orlando Resort joint ventures. The increase at Boardwalk Pipelines is primarily due to higher contracting rates and utilization-based revenues on gas transportation, as well as higher rates on storage, parking and lending.
35 | ||||||||
CNA Financial
The following table summarizes the results of operations for CNA for the three months ended March 31, 2026 and 2025 as presented in Note 12 of the Notes to Consolidated Condensed Financial Statements included under Item 1 of this Report. For further discussion of Net investment income and Investment gains (losses), see the Investments section of this MD&A.
| Three Months Ended March 31 | 2026 | 2025 | ||||||||||||||||||
| (In millions) | ||||||||||||||||||||
| Revenues: | ||||||||||||||||||||
| Insurance premiums | $ | 2,701 | $ | 2,626 | ||||||||||||||||
| Net investment income | 610 | 604 | ||||||||||||||||||
| Investment losses | (18) | (9) | ||||||||||||||||||
| Non-insurance warranty revenue | 374 | 397 | ||||||||||||||||||
| Other revenues | 10 | 9 | ||||||||||||||||||
| Total | 3,677 | 3,627 | ||||||||||||||||||
| Expenses: | ||||||||||||||||||||
| Insurance claims and policyholders’ benefits | 2,175 | 2,027 | ||||||||||||||||||
| Amortization of deferred acquisition costs | 476 | 471 | ||||||||||||||||||
| Non-insurance warranty expense | 356 | 385 | ||||||||||||||||||
| Other operating expenses | 370 | 363 | ||||||||||||||||||
| Interest | 33 | 32 | ||||||||||||||||||
| Total | 3,410 | 3,278 | ||||||||||||||||||
| Income before income tax | 267 | 349 | ||||||||||||||||||
| Income tax expense | (56) | (75) | ||||||||||||||||||
| Net income | 211 | 274 | ||||||||||||||||||
| Amounts attributable to noncontrolling interests | (17) | (22) | ||||||||||||||||||
| Net income attributable to Loews Corporation | $ | 194 | $ | 252 | ||||||||||||||||
Net income attributable to Loews Corporation decreased $58 million for the three months ended March 31, 2026 as compared with the comparable 2025 period, primarily due to lower underlying underwriting results and unfavorable net prior year loss reserve development, partially offset by higher net investment income.
CNA’s Property & Casualty and Other Insurance Operations
CNA’s commercial property and casualty insurance operations (“Property & Casualty Operations”) include its Specialty, Commercial and International lines of business. CNA’s Other Insurance Operations outside of Property & Casualty Operations include its long-term care business that is in run-off, certain corporate expenses, including interest on CNA’s corporate debt, and the results of certain property and casualty businesses in run-off, including asbestos and environmental pollution (“A&EP”), a legacy portfolio of excess workers’ compensation (“EWC”) policies and certain legacy mass tort reserves. We believe the presentation of CNA as one reportable segment is appropriate in accordance with applicable accounting standards on segment reporting. However, for purposes of this discussion and analysis of the results of operations, we provide greater detail with respect to CNA’s Property & Casualty Operations and Other Insurance Operations to enhance the reader’s understanding and to provide further transparency into key drivers of CNA’s financial results.
In assessing its insurance operations, CNA utilizes the core income (loss) financial measure. Core income (loss) is calculated by excluding investment gains or losses and gains or losses resulting from pension settlement transactions from net income (loss). In addition, core income (loss) excludes the effects of noncontrolling interests. The calculation of core income (loss) excludes investment gains or losses because they are generally driven by economic factors that are not necessarily reflective of CNA’s primary insurance operations. The calculation of core income (loss) excludes gains or losses resulting from pension settlement transactions as they result from decisions regarding CNA’s defined benefit pension plans which are unrelated to its primary insurance operations. Core income (loss) is deemed to be a non-GAAP
36 | ||||||||
financial measure and management believes some investors may find this measure useful to evaluate CNA’s insurance operations. Please see the non-GAAP reconciliation of net income (loss) to core income (loss) in this MD&A.
In evaluating the results of Property & Casualty Operations CNA utilizes the loss ratio, the underlying loss ratio, the expense ratio, the dividend ratio, the combined ratio and the underlying combined ratio. These ratios are calculated using GAAP financial results. The loss ratio is the percentage of net incurred claim and claim adjustment expenses to net earned premiums. The underlying loss ratio excludes the impact of catastrophe-related reinstatement premiums, catastrophe losses and development-related items from the loss ratio. Development-related items represent net prior year loss reserve and premium development, and includes the effects of interest accretion and change in allowance for uncollectible reinsurance. The expense ratio is the percentage of insurance underwriting and acquisition expenses, including the amortization of deferred acquisition costs, to net earned premiums. The dividend ratio is the ratio of policyholders’ dividends incurred to net earned premiums. The combined ratio is the sum of the loss ratio, the expense ratio and the dividend ratio. The underlying combined ratio is the sum of the underlying loss ratio, the expense ratio and the dividend ratio. The underlying loss ratio and the underlying combined ratio are deemed to be non-GAAP financial measures, and management believes some investors may find these ratios useful to evaluate CNA’s underwriting performance since they remove the impact of catastrophes which are unpredictable as to timing and amount, and development-related items as they are not indicative of current year underwriting performance.
Changes in estimates of claim and claim adjustment expense reserves, net of reinsurance, for prior years are defined as net prior year loss reserve development within this MD&A. These changes can be favorable or unfavorable. Net prior year loss reserve development does not include the effect of any related acquisition expenses. Further information on CNA’s reserves is provided in Notes 4 and 5 of the Notes to Consolidated Condensed Financial Statements included under Item 1 of this Report.
In addition, renewal premium change, rate, retention and new business are also utilized in evaluating operating trends. Renewal premium change represents the estimated change in average premium on policies that renew, including rate and exposure changes. Rate represents the average change in price on policies that renew excluding exposure change. Exposure represents the measure of risk used in the pricing of the insurance product. The change in exposure represents the change in premium dollars on policies that renew as a result of the change in risk of the policy. Retention represents the percentage of premium dollars renewed, excluding rate and exposure changes, in comparison to the expiring premium dollars from policies available to renew. New business represents premiums from policies written with new customers and additional policies written with existing customers.
CNA also uses underwriting gain (loss) and underlying underwriting gain (loss), calculated using GAAP financial results, to monitor insurance operations. Underwriting gain (loss) is deemed to be a non-GAAP financial measure and is calculated pretax as net earned premiums less total insurance expenses, which includes insurance claims and policyholders’ benefits, amortization of deferred acquisition costs and insurance related administrative expenses. Net income (loss) is the most directly comparable GAAP measure. Management believes some investors may find this measure useful to evaluate the profitability, before tax, derived from CNA’s underwriting activities, which are managed separately from its investing activities. Underlying underwriting gain (loss) is also deemed to be a non-GAAP financial measure, and represents pretax underwriting gain (loss) excluding catastrophe-related reinstatement premiums, catastrophe losses and development-related items. Management believes some investors may find this measure useful to evaluate the profitability, before tax, derived from CNA’s underwriting activities, excluding the impact of catastrophes, which are unpredictable as to timing and amount, and development-related items as they are not indicative of CNA’s current year underwriting performance.
37 | ||||||||
The following tables present reconciliations of net income attributable to Loews Corporation to core income (loss), underwriting gain (loss) and underlying underwriting gain for the three months ended March 31, 2026 and 2025:
| Three Months Ended March 31, 2026 | Specialty | Commercial | International | Property & Casualty | Other Insurance Operations | Total | |||||||||||||||||||||||||||||
| (In millions) | |||||||||||||||||||||||||||||||||||
| Net income (loss) attributable to Loews Corporation | $ | 87 | $ | 97 | $ | 33 | $ | 217 | $ | (23) | $ | 194 | |||||||||||||||||||||||
| Investment losses | 4 | 7 | 1 | 12 | 2 | 14 | |||||||||||||||||||||||||||||
| Noncontrolling interests | 8 | 8 | 3 | 19 | (2) | 17 | |||||||||||||||||||||||||||||
| Core income (loss) | $ | 99 | $ | 112 | $ | 37 | $ | 248 | $ | (23) | $ | 225 | |||||||||||||||||||||||
| Less: | |||||||||||||||||||||||||||||||||||
| Net investment income | 142 | 190 | 43 | 375 | |||||||||||||||||||||||||||||||
| Non-insurance warranty revenue | 18 | 18 | |||||||||||||||||||||||||||||||||
| Other expense, including interest expense | (11) | (2) | (2) | (15) | |||||||||||||||||||||||||||||||
| Income tax expense on core income | (26) | (27) | (18) | (71) | |||||||||||||||||||||||||||||||
| Underwriting gain (loss) | (24) | (49) | 14 | (59) | |||||||||||||||||||||||||||||||
| Catastrophe-related reinstatement premiums | 9 | 9 | |||||||||||||||||||||||||||||||||
| Catastrophe losses | 84 | 4 | 88 | ||||||||||||||||||||||||||||||||
| Effect of unfavorable development-related items | 50 | 56 | 106 | ||||||||||||||||||||||||||||||||
| Underlying underwriting gain | $ | 26 | $ | 100 | $ | 18 | $ | 144 | |||||||||||||||||||||||||||
38 | ||||||||
| Three Months Ended March 31, 2025 | |||||||||||||||||||||||||||||||||||
| Net income (loss) attributable to Loews Corporation | $ | 137 | $ | 114 | $ | 35 | $ | 286 | $ | (34) | $ | 252 | |||||||||||||||||||||||
| Investment (gains) losses | 1 | (1) | — | 7 | 7 | ||||||||||||||||||||||||||||||
| Noncontrolling interests | 12 | 10 | 3 | 25 | (3) | 22 | |||||||||||||||||||||||||||||
| Core income (loss) | $ | 150 | $ | 124 | $ | 37 | $ | 311 | $ | (30) | $ | 281 | |||||||||||||||||||||||
| Less: | |||||||||||||||||||||||||||||||||||
| Net investment income | 151 | 177 | 34 | 362 | |||||||||||||||||||||||||||||||
| Non-insurance warranty revenue | 12 | 12 | |||||||||||||||||||||||||||||||||
| Other revenue (expense), including interest expense | (14) | (2) | 1 | (15) | |||||||||||||||||||||||||||||||
| Income tax expense on core income | (41) | (34) | (13) | (88) | |||||||||||||||||||||||||||||||
| Underwriting gain (loss) | 42 | (17) | 15 | 40 | |||||||||||||||||||||||||||||||
| Catastrophe losses | 86 | 11 | 97 | ||||||||||||||||||||||||||||||||
| Effect of unfavorable development-related items | 10 | 53 | 63 | ||||||||||||||||||||||||||||||||
| Underlying underwriting gain | $ | 52 | $ | 122 | $ | 26 | $ | 200 | |||||||||||||||||||||||||||
39 | ||||||||
Property & Casualty Operations
The following tables summarize the results of CNA’s Property & Casualty Operations and provides the components to reconcile the combined ratio and loss ratio to the underlying combined ratio and underlying loss ratio for the three months ended March 31, 2026 and 2025.
| Three Months Ended March 31, 2026 | Specialty | Commercial | International | Total | |||||||||||||||||||
| (In millions, except %) | |||||||||||||||||||||||
| Net written premiums | $ | 834 | $ | 1,480 | $ | 308 | $ | 2,622 | |||||||||||||||
| Net earned premiums | 852 | 1,412 | 334 | 2,598 | |||||||||||||||||||
| Underwriting gain (loss) | (24) | (49) | 14 | (59) | |||||||||||||||||||
| Net investment income | 142 | 190 | 43 | 375 | |||||||||||||||||||
| Core income | 99 | 112 | 37 | 248 | |||||||||||||||||||
| Other performance metrics: | |||||||||||||||||||||||
| Loss ratio | 68.7 | % | 76.2 | % | 61.0 | % | 71.8 | % | |||||||||||||||
| Expense ratio | 33.6 | 26.7 | 34.9 | 29.9 | |||||||||||||||||||
| Dividend ratio | 0.4 | 0.6 | 0.5 | ||||||||||||||||||||
| Combined ratio | 102.7 | % | 103.5 | % | 95.9 | % | 102.2 | % | |||||||||||||||
| Less: Effect of catastrophe impacts | 6.4 | 1.2 | 3.6 | ||||||||||||||||||||
| Less: Effect of unfavorable development-related items | 5.9 | 4.0 | 4.1 | ||||||||||||||||||||
| Underlying combined ratio | 96.8 | % | 93.1 | % | 94.7 | % | 94.5 | % | |||||||||||||||
| Underlying loss ratio | 62.8 | % | 65.8 | % | 59.8 | % | 64.1 | % | |||||||||||||||
| Rate | 3 | % | 2 | % | (4)% | 2 | % | ||||||||||||||||
| Renewal premium change | 5 | 3 | (2) | 3 | |||||||||||||||||||
| Retention | 86 | 81 | 85 | 83 | |||||||||||||||||||
| New business | $ | 127 | $ | 369 | $ | 85 | $ | 581 | |||||||||||||||
| Three Months Ended March 31, 2025 | |||||||||||||||||||||||
| Net written premiums | $ | 842 | $ | 1,498 | $ | 266 | $ | 2,606 | |||||||||||||||
| Net earned premiums | 830 | 1,380 | 310 | 2,520 | |||||||||||||||||||
| Underwriting gain (loss) | 42 | (17) | 15 | 40 | |||||||||||||||||||
| Net investment income | 151 | 177 | 34 | 362 | |||||||||||||||||||
| Core income | 150 | 124 | 37 | 311 | |||||||||||||||||||
| Other performance metrics: | |||||||||||||||||||||||
| Loss ratio | 61.4 | % | 73.0 | % | 62.1 | % | 67.8 | % | |||||||||||||||
| Expense ratio | 33.4 | 27.6 | 33.3 | 30.2 | |||||||||||||||||||
| Dividend ratio | 0.3 | 0.5 | 0.4 | ||||||||||||||||||||
| Combined ratio | 95.1 | % | 101.1 | % | 95.4 | % | 98.4 | % | |||||||||||||||
| Less: Effect of catastrophe impacts | 6.3 | 3.6 | 3.8 | ||||||||||||||||||||
| Less: Effect of favorable development-related items | 1.3 | 3.8 | 2.5 | ||||||||||||||||||||
| Underlying combined ratio | 93.8 | % | 91.0 | % | 91.8 | % | 92.1 | % | |||||||||||||||
| Underlying loss ratio | 60.1 | % | 62.9 | % | 58.5 | % | 61.5 | % | |||||||||||||||
| Rate | 3 | % | 6 | % | (2)% | 4 | % | ||||||||||||||||
| Renewal premium change | 4 | 7 | 1 | 6 | |||||||||||||||||||
| Retention | 89 | 84 | 85 | 86 | |||||||||||||||||||
| New business | $ | 112 | $ | 370 | $ | 83 | $ | 565 | |||||||||||||||
Net written premiums for Specialty decreased $8 million for the three months ended March 31, 2026 as compared with the comparable 2025 period driven by lower retention partially offset by rate and new business. The increase in net earned premiums for the three months ended March 31, 2026 was consistent with the trend in net written premiums in recent quarters for Specialty.
40 | ||||||||
Net written premiums for Commercial decreased $18 million for the three months ended March 31, 2026 as compared with the comparable 2025 period driven by lower retention. The increase in net earned premiums for the three months ended March 31, 2026 was consistent with the trend in net written premiums in recent quarters for Commercial.
Net written premiums for International increased $42 million for the three months ended March 31, 2026 as compared with the comparable 2025 period. Excluding the effect of foreign currency exchange rates, net written premiums increased $19 million for the three months ended March 31, 2026 as compared with the comparable 2025 period driven by timing of reinsurance costs, partially offset by lower rate. The increase in net earned premiums for the three months ended March 31, 2026 was consistent with the trend in net written premiums for International.
Core income for Property & Casualty Operations decreased $63 million for the three months ended March 31, 2026 as compared with the comparable 2025 period primarily driven by lower underlying underwriting results and unfavorable net prior year loss reserve development, partially offset by higher net investment income.
Catastrophe losses for Property & Casualty Operations were $88 million and catastrophe-related reinsurance reinstatement premiums were $9 million for the three months ended March 31, 2026 driven by severe weather related events. Catastrophe losses were $97 million for the comparable 2025 period, driven by severe weather related events, including $53 million for the California wildfires. There were no catastrophe-related reinsurance reinstatement premiums for the three months ended March 31, 2025. For the three months ended March 31, 2026 and 2025, Specialty had no catastrophe losses, Commercial had catastrophe losses of $84 million and $86 million and International had catastrophe losses of $4 million and $11 million. The three months ended March 31, 2026 also includes $9 million of catastrophe-related reinsurance reinstatement premiums for Commercial.
Unfavorable net prior year loss reserve development for Property & Casualty Operations of $100 million and $61 million was recorded for the three months ended March 31, 2026 and 2025. For the three months ended March 31, 2026 and 2025, Specialty recorded unfavorable net prior year loss reserve development of $45 million and $10 million, Commercial recorded unfavorable net prior year loss reserve development of $55 million and $51 million and International recorded no net prior year loss reserve development. Further information on net prior year loss reserve development is included in Note 4 of the Notes to Consolidated Condensed Financial Statements included under Item 1 of this Report.
Specialty’s combined ratio increased 7.6 points for the three months ended March 31, 2026 as compared with the comparable 2025 period primarily due to a 7.3 point increase in the loss ratio. The increase in the loss ratio was due to higher unfavorable net prior year loss reserve development driven by CNA’s professional errors and omissions (“E&O”) business in recent accident years and an increase in the underlying loss ratio driven by loss cost trends exceeding rate for certain lines in recent quarters. The expense ratio was generally consistent with the comparable 2025 period.
Commercial’s combined ratio increased 2.4 points for the three months ended March 31, 2026 as compared with the comparable 2025 period primarily due to a 3.2 point increase in the loss ratio partially offset by a 0.9 point improvement in the expense ratio. The increase in the loss ratio was driven by a higher underlying loss ratio in excess casualty and workers’ compensation. The improvement in the expense ratio was primarily driven by a lower acquisition ratio. The effect of catastrophe impacts on the loss ratio was 6.4 points for the three months ended March 31, 2026 as compared with 6.3 points for the comparable 2025 period.
International’s combined ratio increased 0.5 points for the three months ended March 31, 2026 as compared with the comparable 2025 period due to a 1.6 point increase in the expense ratio, partially offset by a 1.1 point improvement in the loss ratio. The increase in the expense ratio was primarily driven by higher employee related costs and acquisition costs partially offset by higher net earned premiums. The improvement in the loss ratio was primarily driven by lower catastrophe losses, which were 1.2 points of the loss ratio for the three months ended March 31, 2026 as compared with 3.6 points of the loss ratio for the comparable 2025 period, partially offset by an increase in the underlying loss ratio driven by continued pricing pressure.
41 | ||||||||
Other Insurance Operations
The following table summarizes the results of CNA’s Other Insurance Operations for the three months ended March 31, 2026 and 2025.
| Three Months Ended March 31 | 2026 | 2025 | ||||||||||||||||||
| (In millions) | ||||||||||||||||||||
| Net earned premiums | $ | 103 | $ | 106 | ||||||||||||||||
| Net investment income | 235 | 242 | ||||||||||||||||||
| Core loss | (23) | (30) | ||||||||||||||||||
Core results for Other Insurance Operations improved $7 million for the three months ended March 31, 2026 as compared with the comparable 2025 period, primarily due to no net prior year loss reserve development in the current year as compared with a $17 million after-tax charge in 2025 related to unfavorable net prior year loss reserve development largely associated with legacy mass tort abuse reserves. Core loss also includes amortization of the deferred gain related to the asbestos and environmental pollution (“A&EP”) loss portfolio transfer (“LPT”). Further information on the net prior year loss reserve development and the A&EP LPT is included in Note 4 of the Notes to Consolidated Condensed Financial Statements included under Item 1 of this Report. Long-term care results for the three months ended March 31, 2026 reflect unfavorable morbidity partially offset by favorable persistency. Long-term care results for the comparable 2025 period reflected favorable persistency.
42 | ||||||||
Boardwalk Pipelines
Current Growth Projects
Boardwalk Pipelines regularly reviews opportunities to expand its existing facilities and footprint to meet growing demand for transportation and storage services. The recent growth of liquefied natural gas export and power generation demand has led to the announcement of additional growth projects for Boardwalk Pipelines. Through the date of this filing, Boardwalk Pipelines has growth projects for which it has executed precedent or long-term firm transportation agreements that are expected to increase capacity on its pipeline systems by an aggregate of 4.2 billion cubic feet per day (“Bcf/d”) and its storage working gas capacity by 10 Bcf at an expected aggregate cost of approximately $3.2 billion and are scheduled to be completed through 2030. As of March 31, 2026, Boardwalk Pipelines has spent $245 million on these growth projects. These projects remain contingent upon, among other things, the receipt of required regulatory approvals and permits and are subject to construction risk.
These projects have lengthy planning and construction periods and, as a result, will not contribute to Boardwalk Pipelines’ earnings and cash flows until they receive the required regulatory approvals and permits and are constructed and placed into service over the next several years. For further discussion of capital expenditures and financing, please see Liquidity and Capital Resources: Subsidiaries of this MD&A. Boardwalk Pipelines’ cost and timing estimates for these projects are based on a variety of inputs such as contractor indicative bids, quotes on materials and internally-developed financial models, metrics and timelines and are subject to a variety of risks and uncertainties, including obtaining timely regulatory and permit approvals and the cost thereof, adverse weather conditions during construction, its ability to acquire and the cost of obtaining rights to construct and operate on land not owned by Boardwalk Pipelines, delays in obtaining and shortages and price increases for key materials (including pipe, compressor facilities and related equipment), tariff implications and shortages and increased costs of qualified labor. Factors in the estimates include, among other things, those related to pipeline costs based on mileage, size and type of pipe, materials including compressors and related equipment, land, engineering and construction costs and timely receipt of all necessary permits and approvals. Actual costs and timing of in-service dates for Boardwalk Pipelines’ growth projects may differ, perhaps materially, from its estimates. In addition, failure to timely meet development milestones may result in, among other things, contractual counterparties having the ability to terminate contracts with Boardwalk Pipelines. Refer to Part I, Item 1. Business and Part I, Item 1A. Risk Factors in our Annual Report on Form 10-K for the year ended December 31, 2025 for project descriptions and additional risks associated with Boardwalk Pipelines’ growth projects and the related financing.
43 | ||||||||
Boardwalk Pipelines’ more significant growth projects are listed below:
| Expected in-service date | Expected incremental capacity added to system (Bcf/d) | |||||||
| Eunice - Iowa (a) | Third quarter 2026 | 0.1 | ||||||
| Carnation Project (b) | Fourth quarter 2027 | 0.2 | ||||||
| Northeast Texas Power Plant Project (c) | Fourth quarter 2027 | 0.3 | ||||||
| Kosciusko Junction Project (c) | First half 2028 | 1.2 | ||||||
| Ohio Power Plant Project (c) | First half 2028 | 0.3 | ||||||
| Southeast Compression for Utility Reliability Expansion Project (c) | First half 2028 | 0.3 | ||||||
| Parks Line Upgrade and Sorrento Station Project (d) | First half 2028 | 0.2 | ||||||
| Texas Gateway Project (c) | Second half 2029 | 1.5 | ||||||
| Petal Gas Storage Expansion (e) | Second half 2030 | (e) | ||||||
| (a) | This project has received approval from the Federal Energy Regulatory Commission (“FERC”) and is in construction. | ||||||||||
| (b) | This project remains subject to FERC approval and receipt of environmental permits and authorizations. | ||||||||||
| (c) | These projects remain subject to FERC approval, acquisition of land rights and receipt of environmental permits and authorizations. | ||||||||||
| (d) | This project received FERC approval in December 2025 and is expected to start construction in the first half of 2026. | ||||||||||
| (e) | This project remains subject to FERC approval and is expected to add 10 Bcf of storage working gas capacity. | ||||||||||
Refer to Current Growth Projects in Part I, Item 1. Business in our Annual Report on Form 10-K for the year ended December 31, 2025 for further discussion of Boardwalk Pipelines’ significant growth projects. Boardwalk Pipelines’ growth projects include $9.5 billion of estimated revenues that are anticipated under executed precedent or long-term firm transportation agreements for growth projects that are contingent upon, among other things, receipt of required regulatory approvals and permits and are subject to construction risk.
In addition to growth projects for which Boardwalk Pipelines has executed precedent agreements, it regularly considers other potential growth projects at earlier stages of development, and is currently evaluating additional growth projects involving substantial capital commitments. Boardwalk Pipelines may from time to time make public disclosures regarding these potential projects, for instance, through announcements of open seasons for potential future capacity. In addition to the risks, uncertainties and contingencies described above regarding the growth projects for which Boardwalk Pipelines has executed precedent agreements, these potential growth projects at earlier stages of development are subject to a variety of additional risks and uncertainties as Boardwalk Pipelines has not reached final investment decisions or secured executed precedent agreements for them. Therefore, these potential growth projects at earlier stages of development may not be consummated as contemplated in any such public disclosures or at all.
Results of Operations
Boardwalk Pipelines operates in the midstream portion of the natural gas and natural gas liquids, olefins and other hydrocarbons industry, providing transportation and storage for those commodities. Boardwalk Pipelines also provides ethane supply and transportation services for petrochemical customers in Louisiana and Texas. A significant portion of Boardwalk Pipelines’ revenues is fee-based, being derived from capacity reservation charges under firm agreements with customers, which do not vary significantly period to period, but are impacted by longer term trends in its business such as changes in pricing on contract renewals and other factors as discussed in our Annual Report on Form 10-K for the year ended December 31, 2025. The pricing contained in the purchase and sales agreements associated with Boardwalk Pipelines’ ethane supply services is generally based on the same ethane commodity index, plus a fixed delivery fee. As a result, except for possible timing differences that may occur when volumes are purchased in one month and sold in another month, Boardwalk Pipelines’ ethane supply services, like its other businesses, has little to no direct commodity price exposure. For further information on Boardwalk Pipelines’ revenue recognition policies see Note 1 of the Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2025. Boardwalk Pipelines’
44 | ||||||||
operation and maintenance expenses are impacted by its compliance with the requirements of, among other regulations, pipeline integrity maintenance regulations and its efforts to monitor, control and reduce emissions, as further discussed in Results of Operations of our MD&A included under Item 7 of our Annual Report on Form 10-K for the year ended December 31, 2025.
The following table summarizes the results of operations for Boardwalk Pipelines for the three months ended March 31, 2026 and 2025, as presented in Note 12 of the Notes to Consolidated Condensed Financial Statements included under Item 1 of this Report. Boardwalk Pipelines also utilizes a non-GAAP measure, earnings before interest, income tax expense, depreciation and amortization (“EBITDA”) as a financial measure to assess its operating and financial performance and return on invested capital. Management believes some investors may find this measure useful in evaluating Boardwalk Pipelines’ performance as EBITDA is a commonly used metric within the midstream industry.
| Three Months Ended March 31 | 2026 | 2025 | ||||||||||||||||||
| (In millions) | ||||||||||||||||||||
| Revenues: | ||||||||||||||||||||
| Operating revenues and other | $ | 626 | $ | 621 | ||||||||||||||||
| Interest income | 5 | 1 | ||||||||||||||||||
| Total | 631 | 622 | ||||||||||||||||||
| Expenses: | ||||||||||||||||||||
| Operating and other: | ||||||||||||||||||||
| Operating costs and expenses | 266 | 275 | ||||||||||||||||||
| Depreciation and amortization | 111 | 106 | ||||||||||||||||||
| Interest | 43 | 39 | ||||||||||||||||||
| Total | 420 | 420 | ||||||||||||||||||
| Income before income tax | 211 | 202 | ||||||||||||||||||
| Income tax expense | (52) | (50) | ||||||||||||||||||
| Net income attributable to Loews Corporation | $ | 159 | $ | 152 | ||||||||||||||||
| EBITDA | $ | 360 | $ | 346 | ||||||||||||||||
Net income attributable to Loews Corporation and EBITDA increased $7 million and $14 million for the three months ended March 31, 2026 as compared with the comparable 2025 period, primarily due to the reasons discussed below.
Total revenues increased $9 million for the three months ended March 31, 2026 as compared with the comparable 2025 period. Transportation revenues for the natural gas business increased $8 million for the three months ended March 31, 2026 as compared with the comparable 2025 period, primarily due to higher contracting rates, recently completed growth projects and higher utilization-based revenue. Transportation revenues for the natural gas liquids business increased by $7 million for the three months ended March 31, 2026 as compared with the comparable 2025 period, primarily due to higher volumes. Storage and parking and lending (“PAL”) revenues for the natural gas business increased by $15 million for the three months ended March 31, 2026 as compared with the comparable 2025 period, primarily due to favorable market conditions which allowed for contracting at higher rates. In the natural gas liquids business, ethane product sales decreased by $33 million for the three months ended March 31, 2026 as compared with the comparable 2025 period primarily due to lower volumes, partially offset by higher propane and ethylene product sales of $7 million.
Operating and other expenses decreased $4 million for the three months ended March 31, 2026 as compared with the comparable 2025 period, primarily from lower product costs of $30 million related to lower ethane product sales, partially offset by increased product costs of $15 million related to higher propane and ethylene sales. These decreases were partially offset by increased general and administrative costs of $5 million for the three months ended March 31, 2026 as compared with the comparable 2025 period, primarily due to higher employee-related and outside services costs and increased depreciation and amortization expense of $5 million.
Interest expenses increased $4 million for the three months ended March 31, 2026 as compared with the comparable 2025 period due to the pre-financing of a June 2026 debt maturity that was redeemed in March 2026.
45 | ||||||||
Non-GAAP Reconciliation of Net Income Attributable to Loews Corporation to EBITDA
The following table reconciles net income attributable to Loews Corporation to EBITDA for the three months ended March 31, 2026 and 2025:
| Three Months Ended March 31 | 2026 | 2025 | ||||||||||||||||||
(In millions) | ||||||||||||||||||||
| Net income attributable to Loews Corporation | $ | 159 | $ | 152 | ||||||||||||||||
Interest, net | 38 | 38 | ||||||||||||||||||
Income tax expense | 52 | 50 | ||||||||||||||||||
Depreciation and amortization | 111 | 106 | ||||||||||||||||||
EBITDA | $ | 360 | $ | 346 | ||||||||||||||||
Loews Hotels & Co
The following table summarizes the results of operations for Loews Hotels & Co for the three months ended March 31, 2026 and 2025, as presented in Note 12 of the Notes to Consolidated Condensed Financial Statements included under Item 1 of this Report.
| Three Months Ended March 31 | 2026 | 2025 | ||||||||||||||||||
| (In millions) | ||||||||||||||||||||
| Revenues: | ||||||||||||||||||||
| Operating revenue | $ | 218 | $ | 211 | ||||||||||||||||
| Revenues related to reimbursable expenses | 36 | 34 | ||||||||||||||||||
| Total | 254 | 245 | ||||||||||||||||||
| Expenses: | ||||||||||||||||||||
| Operating and other | 175 | 173 | ||||||||||||||||||
| Asset impairments | 9 | |||||||||||||||||||
| Reimbursable expenses | 36 | 34 | ||||||||||||||||||
| Depreciation and amortization | 26 | 24 | ||||||||||||||||||
| Equity income from joint ventures | (44) | (6) | ||||||||||||||||||
| Interest | 15 | 16 | ||||||||||||||||||
| Total | 217 | 241 | ||||||||||||||||||
| Income before income tax | 37 | 4 | ||||||||||||||||||
| Income tax expense | (11) | (4) | ||||||||||||||||||
| Net income attributable to Loews Corporation | $ | 26 | $ | — | ||||||||||||||||
Net income attributable to Loews Corporation increased $26 million for the three months ended March 31, 2026 as compared with the comparable 2025 period primarily due to higher equity income from joint ventures, driven mainly by the Universal Orlando Resort joint ventures, and the other factors discussed below.
Operating revenues increased by $7 million and operating and other expenses increased by $2 million for the three months ended March 31, 2026 as compared with the comparable 2025 period. The increase in operating revenues was primarily due to a higher overall average daily rate and higher food and beverage revenues. The increase in operating and other expenses was from higher hotel operating costs in support of the higher operating revenues.
Equity income from joint ventures increased $38 million for the three months ended March 31, 2026 as compared with the comparable 2025 period. The increase was driven by growth in the overall average daily rate and an increase in both the
46 | ||||||||
number of available and the number of occupied room nights at the Universal Orlando Resort, including those attributable to the three new hotels that opened in 2025. Equity income from joint ventures for the three months ended March 31, 2025 was impacted by an impairment charge recorded at a joint venture hotel that reduced Loews Hotels & Co’s equity income by $9 million and the reduction in distributions for one joint venture property due to property improvement costs.
Corporate
Corporate operations consist primarily of investment income, interest expense and administrative costs at the Parent Company. Investment income includes earnings on cash and short-term investments held at the Parent Company to meet current and future liquidity needs, as well as results of the trading portfolio held at the Parent Company. Corporate also includes the equity method of accounting for Altium Packaging and intercompany eliminations.
The following table summarizes the results of operations for Corporate for the three months ended March 31, 2026 and 2025 as presented in Note 12 of the Notes to Consolidated Condensed Financial Statements included under Item 1 of this Report:
| Three Months Ended March 31 | 2026 | 2025 | ||||||||||||||||||
| (In millions) | ||||||||||||||||||||
| Revenues: | ||||||||||||||||||||
| Net investment loss | $ | (5) | ||||||||||||||||||
| Intercompany eliminations | (2) | |||||||||||||||||||
| Total | (7) | $ | — | |||||||||||||||||
| Expenses: | ||||||||||||||||||||
| Operating and other | 16 | 16 | ||||||||||||||||||
| Equity method loss | 7 | 7 | ||||||||||||||||||
| Interest | 22 | 18 | ||||||||||||||||||
| Total | 45 | 41 | ||||||||||||||||||
| Loss before income tax | (52) | (41) | ||||||||||||||||||
| Income tax benefit | 10 | 7 | ||||||||||||||||||
| Net loss attributable to Loews Corporation | $ | (42) | $ | (34) | ||||||||||||||||
Net loss attributable to Loews Corporation increased $8 million for the three months ended March 31, 2026 as compared with the comparable 2025 period, primarily due to the reasons discussed below.
Net investment results for the Parent Company decreased $5 million for the three months ended March 31, 2026 as compared with the comparable 2025 period, primarily due to lower results from the trading portfolio.
Interest expense increased $4 million for the three months ended March 31, 2026 as compared with the comparable 2025 period, due to the issuance in February of 2026 of the Parent Company’s $500 million aggregate principal amount of 4.9% senior notes due April 1, 2036, the proceeds of which were used to redeem on March 19, 2026 the outstanding $500 million aggregate principal amount of our 3.8% senior notes due April 1, 2026.
LIQUIDITY AND CAPITAL RESOURCES
Parent Company
Parent Company cash and investments, net of receivables and payables, totaled $4.5 billion at March 31, 2026 as compared to $3.9 billion at December 31, 2025. During the three months ended March 31, 2026, we received $691 million in cash dividends and distributions from our subsidiaries: $616 million from CNA, including a special cash dividend of $497 million, and $75 million from Boardwalk Pipelines. Cash outflows during the three months ended March 31, 2026 included the payment of $31 million to fund treasury stock purchases and $13 million of cash dividends to our shareholders. As a holding company we depend on dividends from our subsidiaries and returns on our investment portfolio to fund our obligations. We also have an effective shelf registration statement on file with the Securities and Exchange Commission (“SEC”) under which we may publicly issue an unspecified amount of our debt, equity or hybrid securities from time to time. We are not responsible for the liabilities and obligations of our subsidiaries and there are no Parent Company guarantees.
47 | ||||||||
In February of 2026, we completed a public offering of $500 million aggregate principal amount of 4.9% senior notes due April 1, 2036, the proceeds of which were used to redeem on March 19, 2026 the outstanding $500 million aggregate principal amount of our 3.8% senior notes due April 1, 2026.
Depending on market and other conditions, we may purchase shares of our and our subsidiaries outstanding common stock in the open market (including, with respect to our common stock, in open market transactions that may or may not satisfy all of the conditions of the Rule 10b-18 voluntary safe harbor), in privately negotiated transactions or otherwise. During the three months ended March 31, 2026, we purchased 0.3 million shares of Loews Corporation common stock for $31 million. As of May 1, 2026, there were 205,768,873 shares of Loews Corporation common stock outstanding.
Future uses of our cash may include purchases of our and our subsidiaries’ outstanding common stock, dividends, investing in our subsidiaries and/or to make opportunistic investments. The declaration and payment of future dividends to holders of our common stock will be at the discretion of our Board of Directors and will depend on many factors, including our earnings, financial condition and business needs.
Subsidiaries
CNA’s cash provided by operating activities was $393 million for the three months ended March 31, 2026 as compared with $638 million for the comparable 2025 period. The decrease in cash provided by operating activities was impacted by payments related to specific reinsurance treaties, which occurred during the first quarter of 2026, with such similar amounts paid in the second quarter of 2025. In addition, the decrease quarter over quarter was attributable to an increase in net claim payments, partially offset by increased investment earnings.
CNA paid cash dividends of $2.48 per share on its common stock, including a special cash dividend of $2.00 per share, during the three months ended March 31, 2026. On May 1, 2026, CNA’s Board of Directors declared a quarterly cash dividend of $0.48 per share, payable June 4, 2026 to shareholders of record on May 18, 2026. CNA’s declaration and payment of future dividends is at the discretion of its Board of Directors and will depend on many factors, including CNA’s earnings, financial condition, business needs and regulatory constraints. CNA believes that its present cash flows from operating, investing and financing activities are sufficient to fund its current and expected working capital and debt obligation needs and does not expect this to change in the near term.
Dividends to CNA from Continental Casualty Company (“CCC”), a subsidiary of CNA, are subject to the insurance holding company laws of the State of Illinois, the domiciliary state of CCC. Under these laws, ordinary dividends, or dividends that do not require prior approval by the Illinois Department of Insurance, are determined based on the greater of the prior year’s statutory net income or 10% of statutory surplus as of the end of the prior year, as well as the timing and amount of dividends paid in the preceding 12 months. Additionally, ordinary dividends may only be paid from earned surplus, which is calculated by removing unrealized gains from unassigned surplus. As of March 31, 2026, CCC was in a positive earned surplus position. CCC paid dividends of $585 million and $440 million during the three months ended March 31, 2026 and 2025. The actual level of dividends paid in any year is determined after an assessment of available dividend capacity, holding company liquidity and cash needs as well as the impact the dividends will have on the statutory surplus of the applicable insurance company.
CNA has an effective shelf registration statement on file with the SEC under which it may publicly issue an unspecified amount of debt, equity or hybrid securities from time to time.
Boardwalk Pipelines’ cash provided by operating activities was $246 million for the three months ended March 31, 2026 as compared with $244 million for the comparable 2025 period.
As described in Current Growth Projects above, Boardwalk Pipelines is currently engaged in growth projects for which it has executed precedent or long-term firm transportation agreements. Through the date of this filing, the expected aggregate cost associated with these agreements is approximately $3.2 billion; this cost is expected to be spent through 2030. As of March 31, 2026, Boardwalk Pipelines has spent $245 million on these growth projects. The majority of the capital expenditures for each of these projects is expected to be spent upon receiving FERC approval to begin construction, which is generally 12-18 months prior to the project’s expected in-service date. Boardwalk Pipelines is also evaluating additional growth projects involving substantial capital commitments. Boardwalk Pipelines expects to finance its growth projects through a combination of operating cash flows and the issuance of long-term debt, including borrowings under its revolving credit facility. Boardwalk Pipelines’ cost and timing estimates for its growth projects are subject to a variety of risks and uncertainties, and are based on the factors described in Boardwalk Pipelines: Current Growth Projects in this MD&A. Actual costs and timing of in-service dates for Boardwalk Pipelines’ growth projects may differ, perhaps materially, from its estimates. Refer to Part I, Item 1A, Risk Factors in our Annual Report on Form 10-K for the year ended December 31, 2025 for additional risks associated with Boardwalk Pipelines’ growth projects and the related financing.
48 | ||||||||
The nature of Boardwalk Pipelines’ existing growth projects will require it to enhance or modify its existing assets to accommodate increased operating pressures or changing flow patterns. Boardwalk Pipelines considers capital expenditures associated with the modification or enhancement of existing assets in the context of a growth project to be growth capital to the extent that the modification would not have been made in the absence of the growth project without regard to the condition of the existing assets.
For the three months ended March 31, 2026 and 2025, Boardwalk Pipelines’ capital expenditures were $144 million and $52 million, consisting of growth capital expenditures of $110 million and $16 million and maintenance capital expenditures of $34 million and $36 million.
Additionally, as of March 31, 2026, Boardwalk Pipelines has future capital commitments comprised of binding commitments under purchase orders for materials ordered but not received totaling approximately $467 million, which are expected to be settled through 2028.
As of March 31, 2026, Boardwalk Pipelines had no outstanding borrowings under its revolving credit facility and had the full borrowing capacity of $1.0 billion available. During the first quarter 2026, Boardwalk Pipelines filed a $3.5 billion shelf registration statement with the SEC, under which it may publicly issue debt securities, warrants or rights from time to time, which was declared effective on March 19, 2026. On March 1, 2026, Boardwalk Pipelines redeemed the outstanding $550 million aggregate principal amount of its 6.0% senior notes due June 1, 2026 at a redemption price equal to par plus unpaid and accrued interest. The redemption was funded from the proceeds of the $550 million aggregate principal amount of its 5.4% senior notes due February 15, 2036 issued in 2025. Boardwalk Pipelines believes that its existing capital resources, including its cash and cash equivalents, revolving credit facility and cash flows from operating activities, will be adequate to fund its anticipated obligations over the next twelve months.
During the three months ended March 31, 2026, Boardwalk Pipelines paid a distribution of $75 million to the Company. On April 30, 2026, Boardwalk Pipelines acquired Spire Marketing LLC (previously known as Spire Marketing Inc.), a business engaged in natural gas marketing activities, for $215 million in cash, subject to customary purchase price adjustments. The acquisition is expected to broaden Boardwalk Pipelines’ marketing capabilities and customer reach.
Loews Hotels & Co, through its subsidiaries, has loans, principally mortgage loans, all of which mature beyond twelve months as of March 31, 2026, which it may refinance before they mature. Refinancing any indebtedness, including loans of unconsolidated joint venture partnerships, may require Loews Hotels & Co to make principal pay downs, establish restricted cash reserves or provide guaranties of the subsidiary’s debt.
INVESTMENTS
Investment activities of our non-insurance subsidiaries primarily consist of investments in fixed income securities, including short-term investments. The Parent Company portfolio also includes equity securities, including short sales and derivative instruments. Certain of these types of Parent Company investments generally have greater volatility, less liquidity and greater risk than fixed income investments and are included within Results of Operations – Corporate.
The Parent Company enters into short sales and invests in certain derivative instruments that are used for asset and liability management activities, income enhancements to its portfolio management strategy and to benefit from anticipated future movements in the underlying markets. If such movements do not occur as anticipated, significant losses may occur. Monitoring procedures include senior management review of daily reports of existing positions and valuation fluctuations to seek to ensure that open positions are consistent with the portfolio strategy.
Credit exposure associated with non-performance by counterparties to derivative instruments is generally limited to the uncollateralized change in fair value of the derivative instruments recognized in the Consolidated Condensed Balance Sheets. The risk of non-performance is mitigated by monitoring the creditworthiness of counterparties and diversifying derivatives by using multiple counterparties. Collateral is occasionally required from derivative investment counterparties depending on the amount of the exposure and the credit rating of the counterparty.
Insurance
CNA maintains a large portfolio of fixed maturity and equity securities, including large amounts of corporate and government issued debt securities, residential and commercial mortgage-backed securities, other asset-backed securities and investments in limited partnerships which pursue a variety of long and short investment strategies across a broad array of asset classes. CNA’s investment portfolio supports its obligation to pay future insurance claims and provides investment returns which are an important part of CNA’s overall profitability.
49 | ||||||||
Net Investment Income
The significant components of CNA’s net investment income are presented in the following table. Fixed income securities, as presented, include both fixed maturity securities and non-redeemable preferred stock.
| Three Months Ended March 31 | 2026 | 2025 | ||||||||||||||||||
| (In millions) | ||||||||||||||||||||
| Fixed income securities: | ||||||||||||||||||||
| Taxable fixed income securities | $ | 500 | $ | 496 | ||||||||||||||||
| Tax-exempt fixed income securities | 52 | 34 | ||||||||||||||||||
| Total fixed income securities | 552 | 530 | ||||||||||||||||||
| Limited partnership and common stock investments | 42 | 54 | ||||||||||||||||||
| Other, net of investment expense | 16 | 20 | ||||||||||||||||||
| Net investment income | $ | 610 | $ | 604 | ||||||||||||||||
| Effective income yield for the fixed income securities portfolio | 4.9 | % | 4.8 | % | ||||||||||||||||
| Limited partnership and common stock return for the period | 1.4 | % | 2.0 | % | ||||||||||||||||
CNA’s net investment income increased $6 million for the three months ended March 31, 2026 as compared with the comparable 2025 period, driven by higher income from fixed income securities as a result of a larger invested asset base and favorable reinvestment rates partially offset by lower common stock returns.
50 | ||||||||
Investment Gains (Losses)
The components of CNA’s investment gains (losses) are presented in the following table:
| Three Months Ended March 31 | 2026 | 2025 | ||||||||||||||||||
| (In millions) | ||||||||||||||||||||
| Investment gains (losses): | ||||||||||||||||||||
| Fixed maturity securities: | ||||||||||||||||||||
| Corporate and other bonds | $ | (7) | $ | (9) | ||||||||||||||||
| States, municipalities and political subdivisions | (1) | (1) | ||||||||||||||||||
| Asset-backed | (6) | 1 | ||||||||||||||||||
| Total fixed maturity securities | (14) | (9) | ||||||||||||||||||
| Non-redeemable preferred stock | (4) | |||||||||||||||||||
| Total investment losses | (18) | (9) | ||||||||||||||||||
| Income tax benefit | 4 | 2 | ||||||||||||||||||
| Amounts attributable to noncontrolling interests | 1 | 1 | ||||||||||||||||||
| Investment losses attributable to Loews Corporation | $ | (13) | $ | (6) | ||||||||||||||||
CNA’s pretax investment losses increased $9 million for the three months ended March 31, 2026 as compared with the comparable 2025 period, driven by higher impairment losses and the unfavorable change in fair value of non-redeemable preferred stock.
Further information on CNA’s investment gains and losses is set forth in Note 2 of the Notes to Consolidated Condensed Financial Statements included under Item 1 of this Report.
Portfolio Quality
The following table presents the estimated fair value and net unrealized gains (losses) of CNA’s fixed maturity securities by rating distribution:
March 31, 2026 | December 31, 2025 | ||||||||||||||||||||||
| Estimated Fair Value | Net Unrealized Gains (Losses) | Estimated Fair Value | Net Unrealized Gains (Losses) | ||||||||||||||||||||
| (In millions) | |||||||||||||||||||||||
| U.S. Government, Government agencies and Government-sponsored enterprises | $ | 3,241 | $ | (242) | $ | 3,274 | $ | (228) | |||||||||||||||
| AAA | 4,057 | (176) | 3,997 | (136) | |||||||||||||||||||
| AA | 7,125 | (514) | 7,001 | (428) | |||||||||||||||||||
| A | 11,088 | (278) | 11,167 | (140) | |||||||||||||||||||
| BBB | 15,974 | (462) | 16,249 | (223) | |||||||||||||||||||
| Non-investment grade | 1,745 | (83) | 1,714 | (42) | |||||||||||||||||||
| Total | $ | 43,230 | $ | (1,755) | $ | 43,402 | $ | (1,197) | |||||||||||||||
As of March 31, 2026 and December 31, 2025, 1% of CNA’s fixed maturity portfolio was rated internally. Additionally, as of March 31, 2026 and December 31, 2025, CNA assigned an AAA rating to $688 million and $661 million of municipal bonds that were either pre-refunded or backed by mortgage loans guaranteed by a U.S. government agency or sponsored enterprise.
51 | ||||||||
The following table presents CNA’s available-for-sale fixed maturity securities in a gross unrealized loss position by ratings distribution:
March 31, 2026 | Estimated Fair Value | Gross Unrealized Losses | |||||||||
| (In millions) | |||||||||||
| U.S. Government, Government agencies and Government-sponsored enterprises | $ | 2,053 | $ | 271 | |||||||
| AAA | 1,521 | 256 | |||||||||
| AA | 4,256 | 678 | |||||||||
| A | 6,408 | 513 | |||||||||
| BBB | 9,446 | 749 | |||||||||
| Non-investment grade | 1,017 | 101 | |||||||||
| Total | $ | 24,701 | $ | 2,568 | |||||||
The following table presents the maturity profile for these available-for-sale fixed maturity securities. Securities not due to mature on a single date are allocated based on weighted average life:
March 31, 2026 | Estimated Fair Value | Gross Unrealized Losses | |||||||||
| (In millions) | |||||||||||
| Due in one year or less | $ | 886 | $ | 10 | |||||||
| Due after one year through five years | 6,626 | 294 | |||||||||
| Due after five years through ten years | 7,157 | 658 | |||||||||
| Due after ten years | 10,032 | 1,606 | |||||||||
| Total | $ | 24,701 | $ | 2,568 | |||||||
Duration
A primary objective in the management of CNA’s investment portfolio is to optimize return relative to the corresponding liabilities and respective liquidity needs. CNA’s views on the current interest rate environment, tax regulations, asset class valuations, specific security issuer and broader industry segment conditions as well as domestic and global economic conditions, are some of the factors that enter into an investment decision. CNA also continually monitors exposure to issuers of securities held and broader industry sector exposures and may from time to time adjust such exposures based on its views of a specific issuer or industry sector.
A further consideration in the management of CNA’s investment portfolio is the characteristics of the corresponding liabilities and the ability to align the duration of the portfolio to those liabilities and to meet future liquidity needs, minimize interest rate risk and maintain a level of income sufficient to support the underlying insurance liabilities. For portfolios where future liability cash flows are determinable and typically long-term in nature, CNA segregates investments for asset/liability management purposes. The segregated investments support the long-term care and structured settlement liabilities in Other Insurance Operations. The effective durations of CNA’s fixed income securities and short-term investments are presented in the following table. Amounts presented are net of payable and receivable amounts for securities purchased and sold, but not yet settled.
52 | ||||||||
March 31, 2026 | December 31, 2025 | ||||||||||||||||||||||
| Estimated Fair Value | Effective Duration (Years) | Estimated Fair Value | Effective Duration (Years) | ||||||||||||||||||||
| (In millions of dollars) | |||||||||||||||||||||||
| Life & Group | $ | 15,271 | 9.5 | $ | 15,584 | 9.7 | |||||||||||||||||
| Property & Casualty and other | 29,884 | 4.6 | 30,716 | 4.5 | |||||||||||||||||||
| Total | $ | 45,155 | 6.3 | $ | 46,300 | 6.3 | |||||||||||||||||
CNA’s investment portfolio is periodically analyzed for changes in duration and related price risk. Certain securities have duration characteristics that are variable based on market interest rates, credit spreads and other factors that may drive variability in the amount and timing of cash flows. Additionally, CNA periodically reviews the sensitivity of the portfolio to the level of foreign exchange rates and other factors that contribute to market price changes. A summary of these risks and specific analysis on changes is included in the Quantitative and Qualitative Disclosures about Market Risk included under Item 7A of our Annual Report on Form 10-K for the year ended December 31, 2025.
CRITICAL ACCOUNTING ESTIMATES
Certain accounting policies require us to make estimates and judgments that affect the amounts reflected in the Consolidated Condensed Financial Statements. Such estimates and judgments necessarily involve varying, and possibly significant, degrees of uncertainty. Accordingly, certain amounts currently recorded or disclosed in the financial statements will likely be adjusted in the future based on new available information and changes in other facts and circumstances. See the Critical Accounting Estimates and the Insurance Reserves sections of our MD&A included under Item 7 of our Annual Report on Form 10-K for the year ended December 31, 2025 for further information.
ACCOUNTING STANDARDS UPDATE
For a discussion of accounting standards updates that have been adopted, please see Note 1 of the Notes to Consolidated Condensed Financial Statements included under Item 1 of this Report.
FORWARD-LOOKING STATEMENTS
Investors are cautioned that certain statements contained in this Report as well as in other of our and our subsidiaries’ SEC filings and press releases and certain statements made by us and our subsidiaries and our and their officials in presentations or remarks may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 (the “Act”). Forward-looking statements include, without limitation, any statement that does not directly relate to any historical or current fact and may project, indicate or imply future results, events, performance or achievements. Such statements may contain the words “expect,” “intend,” “plan,” “anticipate,” “estimate,” “believe,” “will be,” “will continue,” “will likely result,” and similar expressions. In addition, any statement concerning future financial performance (including future revenues, earnings or growth rates), ongoing business strategies or prospects, and possible actions taken by us or our subsidiaries are also forward-looking statements as defined by the Act. Forward-looking statements are based on current expectations and projections about future events and are inherently subject to a variety of risks and uncertainties, many of which are beyond our control, that could cause actual results to differ materially from those anticipated or projected.
Developments in any of the risks or uncertainties facing us or our subsidiaries, including those described under Part I, Item 1A, Risk Factors in our Annual Report on Form 10-K for the year ended December 31, 2025 and in our and our subsidiaries’ other filings with the SEC, could cause our and our subsidiaries’ results to differ materially from results that have been or may be anticipated or projected. Given these risks and uncertainties, investors should not place undue reliance on forward-looking statements. Forward-looking statements speak only as of the date they are made and we and our subsidiaries expressly disclaim any obligation or undertaking to update these statements to reflect any change in expectations or beliefs or any change in events, conditions or circumstances on which any forward-looking statement is based.
53 | ||||||||
Item 3. Quantitative and Qualitative Disclosures about Market Risk.
There were no material changes in our market risk components as of March 31, 2026 from those discussed in the Quantitative and Qualitative Disclosures about Market Risk section included under Item 7A of our Annual Report on Form 10-K for the year ended December 31, 2025. Additional information related to portfolio duration and market conditions is discussed in the Investments section of Management’s Discussion and Analysis of Financial Condition and Results of Operations included under Part I, Item 2.
Item 4. Controls and Procedures.
The Company maintains a system of disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), which is designed to ensure that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act, including this Report, is recorded, processed, summarized and reported on a timely basis. These disclosure controls and procedures include controls and procedures designed to ensure that information required to be disclosed by the Company under the Exchange Act is accumulated and communicated to the Company’s management on a timely basis to allow decisions regarding required disclosure.
The Company’s management, including the Company’s principal executive officer (“CEO”) and principal financial officer (“CFO”) conducted an evaluation of the effectiveness of the Company’s disclosure controls and procedures as of the end of the period covered by this Report and, based on that evaluation, the CEO and CFO concluded that the Company’s disclosure controls and procedures were effective as of March 31, 2026.
There were no changes in the Company’s internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the quarter ended March 31, 2026 that have materially affected or that are reasonably likely to materially affect the Company’s internal control over financial reporting.
PART II. OTHER INFORMATION
Item 1. Legal Proceedings.
Information on our legal proceedings is set forth in Note 10 to the Consolidated Condensed Financial Statements included under Part I, Item 1.
Item 1A. Risk Factors.
Our Annual Report on Form 10-K for the year ended December 31, 2025 includes a discussion of material risk factors facing the Company. There have been no material changes to such risk factors as of the date of this Report.
54 | ||||||||
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
Items 2 (a) and (b) are inapplicable.
(c) STOCK REPURCHASES
| Period | (a) Total number of shares purchased | (b) Average price paid per share | (c) Total number of shares purchased as part of publicly announced plans or programs | (d) Maximum number of shares (or approximate dollar value) of shares that may yet be purchased under the plans or programs (in millions) | |||||||||||||||||||
January 1, 2026 - January 31, 2026 | N/A | N/A | N/A | N/A | |||||||||||||||||||
February 1, 2026 - February 28, 2026 | 144,525 | $ | 108.90 | N/A | N/A | ||||||||||||||||||
March 1, 2026 - March 31, 2026 | 140,651 | 108.72 | N/A | N/A | |||||||||||||||||||
Item 5. Other Information
55 | ||||||||
Item 6. Exhibits.
| Description of Exhibit | Exhibit Number | ||||
| XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document | 101.INS * | ||||
| Inline XBRL Taxonomy Extension Schema | 101.SCH * | ||||
| Inline XBRL Taxonomy Extension Calculation Linkbase | 101.CAL * | ||||
| Inline XBRL Taxonomy Extension Definition Linkbase | 101.DEF * | ||||
| Inline XBRL Taxonomy Label Linkbase | 101.LAB * | ||||
| Inline XBRL Taxonomy Extension Presentation Linkbase | 101.PRE * | ||||
| Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) | 104* | ||||
*Filed herewith.
56 | ||||||||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned, hereunto duly authorized.
| LOEWS CORPORATION | |||||||||||
| (Registrant) | |||||||||||
Dated: May 4, 2026 | By: | /s/ Jane J. Wang | |||||||||
| JANE J. WANG | |||||||||||
| Senior Vice President and Chief Financial Officer (Duly authorized officer and principal financial officer) | |||||||||||
57 | ||||||||
Exhibit 31.1
I, Benjamin J. Tisch, certify that:
1. I have reviewed this quarterly report on Form 10-Q of Loews Corporation;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
| (a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; | |||||||
| (b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; | |||||||
| (c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and | |||||||
| (d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and | |||||||
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
| (a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and | |||||||
| (b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. | |||||||
Date: May 4, 2026 | By: | /s/ Benjamin J. Tisch | ||||||
| BENJAMIN J. TISCH | ||||||||
| Chief Executive Officer | ||||||||
Exhibit 31.2
I, Jane J. Wang, certify that:
1. I have reviewed this quarterly report on Form 10-Q of Loews Corporation;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
| (a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; | |||||||
| (b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; | |||||||
| (c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and | |||||||
| (d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and | |||||||
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
| (a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and | |||||||
| (b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. | |||||||
Date: May 4, 2026 | By: | /s/ Jane J. Wang | ||||||
| JANE J. WANG | ||||||||
| Chief Financial Officer | ||||||||
Exhibit 32.1
Certification by the Chief Executive Officer
of Loews Corporation pursuant to 18 U.S.C. Section 1350
(as adopted by Section 906 of the
Sarbanes-Oxley Act of 2002)
Pursuant to 18 U.S.C. Section 1350, the undersigned chief executive officer of Loews Corporation (the “Company”) hereby certifies, to such officer’s knowledge, that the Company’s quarterly report on Form 10-Q for the quarter ended March 31, 2026 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: May 4, 2026 | By: | /s/ Benjamin J. Tisch | ||||||
| BENJAMIN J. TISCH | ||||||||
| Chief Executive Officer | ||||||||
Exhibit 32.2
Certification by the Chief Financial Officer
of Loews Corporation pursuant to 18 U.S.C. Section 1350
(as adopted by Section 906 of the
Sarbanes-Oxley Act of 2002)
Pursuant to 18 U.S.C. Section 1350, the undersigned chief financial officer of Loews Corporation (the “Company”) hereby certifies, to such officer’s knowledge, that the Company’s quarterly report on Form 10-Q for the quarter ended March 31, 2026 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: May 4, 2026 | By: | /s/ Jane J. Wang | ||||||
| JANE J. WANG | ||||||||
| Chief Financial Officer | ||||||||